Autoimmune Diseases


Clinical Trials for Inflammatory Bowel Disease: Global Guidance During the COVID-19 Pandemic

Reinisch W, Danese S, Peyrin-Biroulet L, Loftus EV.

Abstract:

Link to Article

Correspondence on: 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort' by Pouletty et al

Pino R, Izurieta AC, Ríos-Barnés M, Ricart S, De Sevilla MF, Monfort L, Launes C, Cano I, Lecina L, Sánchez Manubens J, Mosquera JM, Jordan I, Sánchez de Toledo J, Monsonís M, Esteva C, Muñoz-Almagro C, Fumadó V, Fortuny C, Garcia Garcia JJ, Noguera-Julian A, Anton J; Kids Corona Project.

Abstract:

Link to Article

Hydroxychloroquin ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis

Singer ME, Kaelber DC, Antonelli MJ.

Abstract:

Link to Article

Response to: 'Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5 positive dermatomyositis associated rapidly progressive interstitial lung diseases: a challenge for the future' by Wang et al

Lamb JA, Megremis S, Chinoy H.

Abstract:

Link to Article

Response to: 'Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort' by Pouletty et al' by Pino et al

Ouldali N, Pouletty M, Lokmer J, Benzouid C, Beyler C, Deho A, Meinzer U, Faye A, Melki I; Great Paris Region (GPR) Kawa-COVID-19 consortium.

Abstract:

Link to Article

Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5-positive dermatomyositis-associated rapidly progressive interstitial lung diseases: a challenge for the future

Wang Y, Du G, Zhang G, Matucci-Cerinic M, Furst DE.

Abstract:

Link to Article

SARS CoV-2 infection among patients using immunomodulatory therapies

Winthrop KL, Brunton AE, Beekmann S, Polgreen P, Baddley J, Saag KG, Calabrese C, Calabrese L, Robinson PC, Wallace ZS, Curtis JR; COVID-19 Study Team.

Abstract:

Link to Article

Response to: 'Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis' by Singer et al

Ugarte-Gil MF, Konig MF, Korsten P, Berenbaum F, Kim AH, Sparks JA.

Abstract:

Link to Article

COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs

Ansarin K, Taghizadieh A, Safiri S, Malek Mahdavi A, Ranjbar S, Teymouri S, Ahangari Maleki M, Khabbazi A.

Abstract:

Link to Article

Exacerbation of immune thrombocytopaenia triggered by COVID-19 in patients with systemic lupus erythematosus

Kondo Y, Kaneko Y, Oshige T, Fukui H, Saito S, Okayama M, Kamata H, Ishii M, Hasegawa N, Fukunaga K, Takeuchi T.

Abstract:

Link to Article

Response to: 'Exacerbation of immune thrombocytopaenia triggered by COVID-19 in patients with systemic lupus erythematosus' by Kondo et al

Mathian A, Amoura Z.

Abstract:

Link to Article

Severe Acute Respiratory Syndrome Coronavirus 2 and the Use of Biologics in Patients With Psoriasis

Ladda M, Lynde C, Fleming P.

Abstract:

Link to Article

[Recommendations of the German Society for Rheumatology for management of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic - Update July 2020]

Schulze-Koops H, Iking-Konert C, Leipe J, Hoyer BF, Holle J, Moosig F, Aries P, Burmester G, Fiehn C, Krause A, Lorenz HM, Schneider M, Sewerin P, Voormann A, Wagner U, Krüger K, Specker C; Kommission Pharmakotherapie; Vorstand der Deutschen Gesellschaft für Rheumatologie.

Abstract:

Link to Article

Response to: 'Presence of anti-phospholipid antibodies in COVID-19: a case series study' by Amezcua-Guerra et al

Mathian A, Pineton De Chambrun M, Combes A, Amoura Z.

Abstract:

Link to Article

Presence of antiphospholipid antibodies in COVID-19: case series study

Amezcua-Guerra LM, Rojas-Velasco G, Brianza-Padilla M, Vázquez-Rangel A, Márquez-Velasco R, Baranda-Tovar F, Springall R, Gonzalez-Pacheco H, Juárez-Vicuña Y, Tavera-Alonso C, Sanchez-Muñoz F, Hernández-Salas M.

Abstract:

Link to Article

Transient monoarthritis and psoriatic skin lesions following COVID-19

De Stefano L, Rossi S, Montecucco C, Bugatti S.

Abstract:

Link to Article

Treatment of patients with inflammatory rheumatic diseases with rituximab should be carefully considered during the SARS-CoV-2/COVID-19 pandemic. Response to: 'Persistence of rT-PCR-SARS-CoV-2 infection and delayed serological response, as a possible effect of rituximab according to the hypothes

Schulze-Koops H, Krueger K, Vallbracht IV, Hasseli R, Skapenko A.

Abstract:

Link to Article

To immunosuppress: whom, when and how? That is the question with COVID-19

Winthrop KL, Mariette X.

Abstract:

Link to Article

Does immunosuppressive treatment entail an additional risk for children with rheumatic diseases? A survey-based study in the era of COVID-19

Koker O, Demirkan FG, Kayaalp G, Cakmak F, Tanatar A, Karadag SG, Sonmez HE, Omeroglu R, Aktay Ayaz N.

Abstract:

Link to Article

Management of IBD Patients Who Are Unwilling or Unable to Receive Infusion Therapy During the COVID-19 Pandemic

Horrigan JM, Siegel CA, Tadros M.

Abstract:

Link to Article

Targeting IL-6 in COVID-19. Response to: 'Rational use of tocilizumab in COVID-19' by Jain and Sharma

Capecchi PL, Lazzerini PE.

Abstract:

Link to Article

COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine

Teh CL, Cheong YK, Wan Musa WR, Wan Mohd Akbar SA, Mat Husin N, Gun SC.

Abstract:

Link to Article

Response to: 'COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine' by Teh et al

Mathian A, Amoura Z.

Abstract:

Link to Article

Response to: 'Rational use of tocilizumab in COVID-19' by Jain and Sharma

Potere N, Di Nisio M, Cibelli D, Scurti R, Frattari A, Porreca E, Abbate A, Parruti G.

Abstract:

Link to Article

More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia

Ferraccioli G.

Abstract:

Link to Article

Rational use of tocilizumab in COVID-19

Jain S, Sharma SK.

Abstract:

Link to Article

Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: 'More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia' by Ferraccioli

Della-Torre E, Campochiaro C, Cavalli G, De Luca G, Ciceri F, Zangrillo A, Dagna L.

Abstract:

Link to Article

Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy

Talamonti M, Galluzzo M, Chiricozzi A, Quaglino P, Fabbrocini G, Gisondi P, Marzano AV, Potenza C, Conti A, Parodi A, Belloni Fortina A, Bardazzi F, Argenziano G, Rongioletti F, Stingeni L, Micali G, Loconsole F, Venturini M, Bongiorno MR, Feliciani C, Rubegni P, Amerio P, Fargnoli MC, Pigatto P, Savoia P, Nisticò SP, Giustini S, Carugno A, Cannavò SP, Rech G, Prignano F, Offidani A, Lombardo M, Zalaudek I, Bianchi L, Peris K; PSO-BIO-COVID study group.

Abstract:

Link to Article

American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 2

Mikuls TR, Johnson SR, Fraenkel L, Arasaratnam RJ, Baden LR, Bermas BL, Chatham W, Cohen S, Costenbader K, Gravallese EM, Kalil AC, Weinblatt ME, Winthrop K, Mudano AS, Turner A, Saag KG.

Abstract:

Link to Article

Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications

Merrill JT, Erkan D, Winakur J, James JA.

Abstract:

Link to Article

Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome

Scarsi M, Piantoni S, Colombo E, Airó P, Richini D, Miclini M, Bertasi V, Bianchi M, Bottone D, Civelli P, Cotelli MS, Damiolini E, Galbassini G, Gatta D, Ghirardelli ML, Magri R, Malamani P, Mendeni M, Molinari S, Morotti A, Salada L, Turla M, Vender A, Tincani A, Brucato A, Franceschini F, Furloni R, Andreoli L.

Abstract:

Link to Article

Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation pr

Khan A, Cole A, Bhadauria N, El-Hassan M, Abdulla D, Axon T, Fattah Z, Manson JJ, Moreno-Cuesta J, Mukerjee D.

Abstract:

Link to Article

Comment on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M et al

Andreica I, Kiefer D, Rezniczek GA, Jast R, Buehring B, Kiltz U, Baraliakos X, Braun J.

Abstract:

Link to Article

Virtual Rheumatology During COVID-19: A Personal Perspective

Dacre J.

Abstract:

Link to Article

Improving telemedicine and in-person management of rheumatic and autoimmune diseases,during and after COVID-19 pandemic outbreak. Definite need for more Rheumatologists. Response to: 'Can telerheumatology improve rheumatic and musculoskeletal disease service delivery in sub-Saharan Africa?' by A

Caso F, Del Puente A, Girolimetto N, Tasso M, Caso C, Scarpa R, Costa L.

Abstract:

Link to Article

COVID-19 in rheumatic diseases in Italy: first results from the Italian registry of the Italian Society for Rheumatology (CONTROL-19)

Scirè CA, Carrara G, Zanetti A, Landolfi G, Chighizola C, Alunno A, Andreoli L, Caporali R, Gerli R, Sebastiani GD, Valesini G, Sinigaglia L.

Abstract:

Link to Article

Care of the Patient with IBD Requiring Hospitalization During the COVID-19 Pandemic

Allez M, Fleshner P, Gearry R, Lakatos PL, Rubin DT; IOIBD.

Abstract:

Link to Article

Inflammatory bowel disease management during the COVID-19 outbreak: The 10 do's and don'ts from the ECCO-COVID Taskforce

Magro F, Rahier JF, Abeu C, MacMahon E, Hart A, van der Woude CJ, Gordon H, Adamina M, Viget N, Vavricka S, Kucharzik T, Leone S, Siegmund B, Danese S, Peyrin-Biroulet L.

Abstract:

Link to Article

Italian IBD Patients Coping With Covid-19 Emergency: The Mitigating Role of Psychological Readiness to Engage in Self-care

Castellini G, Savarese M, Leone S, Previtali E, Armuzzi A, Graffigna G.

Abstract:

Link to Article

Response to "Italian IBD Patients Coping With COVID-19 Emergency: The Mitigating Role of Psychological Readiness to Engage in Self-Care"

Occhipinti V, Sociale OR, Pastorelli L.

Abstract:

Link to Article

Fogging IBD Management: An Unusual Case of IBD Flare-up During the COVID-19 Outbreak

Rimondi A, Tontini GE, Mazza S, Caprioli F, Sangiovanni A, Lampertico P, Vecchi M.

Abstract:

Link to Article

Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology

Mantovani Cardoso E, Hundal J, Feterman D, Magaldi J.

Abstract:

Link to Article

Determinants of COVID-19 disease severity in patients with underlying rheumatic disease

Santos CS, Morales CM, Álvarez ED, Castro CÁ, Robles AL, Sandoval TP.

Abstract:

Link to Article

Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study

Ramiro S, Mostard RLM, Magro-Checa C, van Dongen CMP, Dormans T, Buijs J, Gronenschild M, de Kruif MD, van Haren EHJ, van Kraaij T, Leers MPG, Peeters R, Wong DR, Landewé RBM.

Abstract:

Link to Article

Comment on: 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al

Karahan S, Cetinkaya A, Aydin K, Aslan Sirakaya H.

Abstract:

Link to Article

COVID-19 prevalence and the impact on quality of life from stringent social distancing in a single large UK rheumatology centre

Cleaton N, Raizada S, Barkham N, Venkatachalam S, Sheeran T, Adizie T, Sapkota H, Singh B, Bateman J.

Abstract:

Link to Article

COVID-19 and Behçet's disease: clinical case series

Espinosa G, Araujo O, Amaro S, Bodro M, Moreno PJ, Moreno R, Ugarte A, Cervera R.

Abstract:

Link to Article

Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences

Ruscitti P, Bruno F, Berardicurti O, Acanfora C, Pavlych V, Palumbo P, Conforti A, Carubbi F, Di Cola I, Di Benedetto P, Cipriani P, Grassi D, Masciocchi C, Iagnocco A, Barile A, Giacomelli R.

Abstract:

Link to Article

Alpha-MSH targeted liposomal nanoparticle for imaging in Inflammatory Bowel Disease (IBD)

Medina TP, Damoah C, Benezra M, Will O, Kairemo K, Humbert J, Seben S, Medina OP.

Abstract:

Link to Article

Interleukin-6 in Rheumatoid Arthritis

Franco P, Laura F, Valentina C, Simona A, Gloria A, Eleonora N.

Abstract:

Link to Article

Leveraging the United States Epicenter to Provide Insights on COVID-19 in Patients with Systemic Lupus Erythematosus

Fernandez-Ruiz R, Masson M, Kim MY, Myers B, Haberman RH, Castillo R, Scher JU, Guttmann A, Carlucci PM, Deonaraine KK, Golpanian M, Robins K, Chang M, Belmont HM, Buyon JP, Blazer AD, Saxena A, Izmirly PM; NYU WARCOV Investigators.

Abstract:

Link to Article

COVID-19 and Inflammatory Bowel Diseases: Risk Assessment, Shared Molecular Pathways, and Therapeutic Challenges

Popa IV, Diculescu M, Mihai C, Cijevschi-Prelipcean C, Burlacu A.

Abstract:

Link to Article

Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients

Canziani LM, Trovati S, Brunetta E, Testa A, De Santis M, Bombardieri E, Guidelli G, Albano G, Folci M, Squadroni M, Beretta GD, Ciccarelli M, Castoldi M, Lleo A, Aghemo A, Vernile L, Malesci A, Omodei P, Angelini C, Badalamenti S, Cecconi M, Cremonesi A, Selmi C; Humanitas and Gavazzeni / Castelli COVID-19 Task Forces.

Abstract:

Link to Article

How infodemic during the COVID-19 outbreak influenced common clinical practice in an Outpatient Service of severe psoriasis

Sacchelli L, Evangelista V, Di Altobrando A, Lacava R, Rucci P, Rosa S, Patrizi A, Bardazzi F.

Abstract:

Link to Article

Challenges in delivering rheumatology care during COVID-19 pandemic

Nune A, Iyengar K, Ahmed A, Sapkota H.

Abstract:

Link to Article

COVID-19 and ethnicity: challenges in rheumatology

Kumar K, Dubey S, Samanta A, Bosworth A, Moorthy A.

Abstract:

Link to Article

Rheumatologists' practice during the Coronavirus disease 2019 (COVID-19) pandemic: a survey in Egypt

Gheita TA, Salem MN, Eesa NN, Khalil NM, Gamal NM, Noor RA, Moshrif AH, Shereef RE, Ismail F, Noshy N, Fawzy RM, Elshebini E, Khalifa I, Saadany HE, Tharwat S, El-Najjar A, Fattah YA, Sallam R, El-Bahnasawy AS, Gharbia O, Hassan E, ElShanawany A, Mohamed EF, Senara S, Ismail M, Nasef SI, Abdalla AM, Elessawi D, Fawzy SM, Alfadl EA, Khalifa A, Abaza NM; ECR COVID19-Study Group.

Abstract:

Link to Article

Comment on Ye et al 'Presence of respiratory failure of COVID-19 infection in rheumatism patients in Wuhan, China'

Chen XH, Yeh CJ, Mo HY, Wei JCC.

Abstract:

Link to Article

Response to: 'Comment on Ye et al 'Presence of respiratory failure of COVID-19 infection in patients with rheumatism in Wuhan, China'' by Chen et al

Zhong J, Ye C, Cai S, Dong L.

Abstract:

Link to Article

Clinical features of patients with rheumatic diseases and COVID-19 infection in Sarawak, Malaysia

Wan SA, Teh CL, Sachdev Manjit Singh B, Cheong YK, Chuah SL, Jobli AT.

Abstract:

Link to Article

Vital corner of diagnostic challenge: eosinophilic granulomatosis with polyangiitis or COVID-19 pneumonia?

Duran E, Kilic L, Durhan G, Inkaya AÇ, Guven GS, Karakaya G, Ariyurek OM, Karadag O.

Abstract:

Link to Article

Response to: 'Clinical features of patients with rheumatic diseases and COVID-19 infection in Sarawak, Malaysia' by Wan et al

Zhong J, Dong L.

Abstract:

Link to Article

American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 and Hyperinflammation in COVID-19. Version 1

Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, Behrens EM, Ferris A, Kernan KF, Schulert GS, Seo P, F Son MB, Tremoulet AH, Yeung RSM, Mudano AS, Turner AS, Karp DR, Mehta JJ.

Abstract:

Link to Article

American College of Rheumatology Guidance for the Management of Children with Pediatric Rheumatic Disease During the COVID-19 Pandemic: Version 1

Wahezi DM, Lo MS, Rubinstein TB, Ringold S, Ardoin SP, Downes KJ, Jones KB, Laxer RM, Pellet Madan R, Mudano AS, Turner AS, Karp DR, Mehta JJ.

Abstract:

Link to Article

Response to: 'Should patients starting biologics be screened for COVID-19?' by Cardenas-de la Garza et al

Landewé RBM, Schulze-Koops H.

Abstract:

Link to Article

Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study

Moreno-Pérez O, Andres M, Leon-Ramirez JM, Sánchez-Payá J, Rodríguez JC, Sánchez R, García-Sevila R, Boix V, Gil J, Merino E.

Abstract:

Link to Article

Anticoagulants and immunosuppressants in COVID-19: Bullets to Defeat MicroCLOTS

Turi S, Nardelli P, Landoni G.

Abstract:

Link to Article

Psoriasis and COVID-19: A narrative review with treatment considerations

Elmas ÖF, Demirbaş A, Kutlu Ö, Bağcıer F, Metin MS, Özyurt K, Akdeniz N, Atasoy M, Türsen Ü, Lotti T.

Abstract:

Link to Article

The attitude of Polish rheumatology patients towards telemedicine in the age of the COVID-19 pandemic

Opinc A, Łukasik Z, Makowska J.

Abstract:

Link to Article

COVID-19: a short message to rheumatologists

Leszczyński P.

Abstract:

Link to Article

Treatment discontinuation and rate of disease transmission in psoriasis patients on biologic therapy during the COVID-19 pandemic - A Canadian Multicenter Retrospective Study

Georgakopoulos JR, Mufti A, Vender R, Yeung J.

Abstract:

Link to Article

Immune thrombocytopenia in a patient with COVID-19

Deruelle E, Ben Hadj Salem O, Sep Hieng S, Pichereau C, Outin H, Jamme M.

Abstract:

Link to Article

Safety of Endoscopy in Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic

Navaneethan U, Lourdusamy D, LehnerNoguera V, Shen B.

Abstract:

Link to Article

Immune Thrombocytopenia Purpura Secondary to COVID-19

Bennett J, Brown C, Rouse M, Hoffmann M, Ye Z.

Abstract:

Link to Article

Reflections on rheumatological aspects of COVID-19

Calabrese LH, Calabrese C.

Abstract:

Link to Article

Severe Autoimmune Hemolytic Anemia in COVID-19 İnfection, Safely Treated with Steroids

Hindilerden F, Yonal-Hindilerden I, Akar E, Yesilbag Z, Kart-Yasar K.

Abstract:

Link to Article

Management of Pediatric Rheumatological Diseases During the Outbreak of COVID-19: Our Experience

Sutera D, Mazza F, Pajno GB, Spagnolo A, Gallizzi R.

Abstract:

Link to Article

Impact of COVID-19 pandemic on patients with SLE: results of a large multicentric survey from India

Goyal M, Patil P, Pathak H, Santhanam S, Goel A, Sharma V, Pandey A, Gupta N, Jain R, Akerkar S, Das P, Dudam R, Mendiratta N, Pandey BD, Cb M, Singh BK, Kumar S, Nolkha N, Jain S, Jain S, Sharma A, Misra DP.

Abstract:

Link to Article

Response to: 'Impact of COVID-19 pandemic on patients with SLE: results of a large multicentric survey from India' by Goyal et al

Mathian A, Amoura Z.

Abstract:

Link to Article

Repeated false-negative tests delayed diagnosis of COVID-19 in a case with granulomatosis with polyangiitis under maintenance therapy with rituximab and concomitant influenza pneumonia

Hakroush S, Franz J, Larsen J, Korsten P, Winkler MS, Tampe B.

Abstract:

Link to Article

COVID-19 complicated by Hashimoto's thyroiditis

Tee LY, Hajanto S, Rosario BH.

Abstract:

Link to Article

Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment

Shah S, Danda D, Kavadichanda C, Das S, Adarsh MB, Negi VS.

Abstract:

Link to Article

Rheumatic disease management in the Campania region of Italy during the COVID-19 pandemic

Masini F, Gjeloshi K, Ferrara R, Pinotti E, Cuomo G.

Abstract:

Link to Article

Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A review

Grange L, Guilpain P, Truchetet ME, Cracowski JL; Société française de pharmacologie et de thérapeutique (SFPT).

Abstract:

Link to Article

Anti-SARS-CoV-2 antibody testing in IBD healthcare professionals: are we currently able to provide COVID-free IBD clinics?

Malickova K, Kratka Z, Luxova S, Bortlik M, Lukas M.

Abstract:

Link to Article

Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic

Haslak F, Yildiz M, Adrovic A, Sahin S, Koker O, Aliyeva A, Barut K, Kasapcopur O.

Abstract:

Link to Article

[Impact of COVID-19 on rheumatological care : A national survey in April 2020]

Freudenberg S, Vossen D.

Abstract:

Link to Article

COVID-19 in patients with rheumatic diseases: what is the real mortality risk?

Marques C, Pinheiro MM, Reis Neto ET, Dantas AT, Ribeiro FM, Melo AKG.

Abstract:

Link to Article

Response to: 'COVID-19 in patients with rheumatic diseases: what is the real mortality risk?' by Marques et al

D'Silva KM, Serling-Boyd N, Wallwork R, Hsu TY, Sparks JA, Wallace ZS.

Abstract:

Link to Article

[Addendum to S3-Guidelines Crohn's disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic - open questions and answers]

Autoren; Collaborators:.

Abstract:

Link to Article

Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty

Aysha AA, Rentsch C, Prentice R, Johnson D, Bryant RV, Ward MG, Costello SP, Lewindon P, Ghaly S, Connor SJ, Begun J, Christensen B.

Abstract:

Link to Article

Social isolation due to the COVID-19 pandemic has led to worse outcomes in females with inflammatory arthritis

Maguire S, O'Shea F.

Abstract:

Link to Article

COVID-19-A theory of autoimmunity to ACE-2

McMillan P, Uhal BD.

Abstract:

Link to Article

Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces

Vispi M, Corradin T, Peccianti C, Feci L, Casini L, Pisani C, Fabbroni S, Corsetti P, Croatto M, Pellegrino M.

Abstract:

Link to Article

Coronavirus disease 2019 (COVID-19) rash in a psoriatic patient treated with Secukinumab: is there a role for Interleukin 17?

Carugno A, Gambini DM, Raponi F, Vezzoli P, Robustelli Test E, Arosio MEG, Callegaro A, Sena P.

Abstract:

Link to Article

Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes

Kastritis E, Kitas GD, Vassilopoulos D, Giannopoulos G, Dimopoulos MA, Sfikakis PP.

Abstract:

Link to Article

Rheumatic disease and COVID-19

Liew JW, Graef ER.

Abstract:

Link to Article

Antirheumatic drugs for COVID-19 treatment based on the phases of the disease: Current concept

Valentini M, Zmerly H.

Abstract:

Link to Article

Optimizing care for psoriatic patients requiring systemic therapies: how will COVID-19 disease transform risk perceptions?

Talamonti M, Tofani L, Bianchi L, Galluzzo M.

Abstract:

Link to Article

Response to: 'Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?' by Santos-Mareno et al

Liew JW, Graef ER, Sparks JA, Kim AH.

Abstract:

Link to Article

Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?

Santos-Moreno P, Buitrago-Garcia D, Villarreal L, Aza A, Cabrera M, Rivero W, Rojas-Villarraga A.

Abstract:

Link to Article

Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study

Potere N, Di Nisio M, Cibelli D, Scurti R, Frattari A, Porreca E, Abbate A, Parruti G.

Abstract:

Link to Article

Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab

Morrison AR, Johnson JM, Griebe KM, Jones MC, Stine JJ, Hencken LN, To L, Bianchini ML, Vahia AT, Swiderek J, Ramesh MS, Peters MA, Smith ZR.

Abstract:

Link to Article

The course of Covid 19 in Inflammatory Bowel Disease: protective role of TNF antagonists Response to: Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry

Cappello M, Busacca A, Guida L.

Abstract:

Link to Article

Basic Immunology may lead to translational therapeutic rationale:: SARS-CoV-2 and Rheumatic Diseases

Gremese E, Ferraccioli ES, Alivernini S, Tolusso B, Ferraccioli G.

Abstract:

Link to Article

Patient´s perspective: psychological burden of the COVID-19 pandemic in 146 psoriatic patients treated with biological drugs and small molecules in real clinical practice

Rodríguez-Villa Lario A, Vega-Díez D, González-Cañete M, Polo-Rodríguez I, Piteiro-Bermejo AB, Herrero-Fernández M, Arévalo-Serrano J, Trasobares-Marugán L, Medina-Montalvo S.

Abstract:

Link to Article

Severe refractory thrombocytopenia in a woman positive for coronavirus disease 2019 with lupus and antiphospholipid syndrome

Hayden A, Vyas-Lahar A, Rella V, Rudinskaya A.

Abstract:

Link to Article

How COVID-19 affects patients receiving anticytokine and JAK inhibitors in rheumatology and dermatology

Jessica Chang TY, Pope JE.

Abstract:

Link to Article

Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARD

Benucci M, Damiani A, Giannasi G, Li Gobbi F, Quartuccio L, Grossi V, Infantino M, Manfredi M.

Abstract:

Link to Article

COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study

Kasap Cuceoglu M, Batu ED, Bilginer Y, Özen S.

Abstract:

Link to Article

Should patients starting biologics be screened for COVID-19?

Cardenas-de la Garza JA, Arvizu-Rivera RI, Galarza-Delgado DA.

Abstract:

Link to Article

Response to: 'COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study' by Cuceoglu et al

Salvarani C, Bajocchi G, Mancuso P, Galli E, Muratore F, Giorgi Rossi P.

Abstract:

Link to Article

Prolonged presence of SARS-CoV-2 in a COVID-19 case with rheumatoid arthritis taking iguratimod treated with ciclesonide

Baba H, Kanamori H, Oshima K, Seike I, Niitsuma-Sugaya I, Takei K, Sato Y, Tokuda K, Aoyagi T.

Abstract:

Link to Article

Questionnaire assessment helps the self-management of patients with inflammatory bowel disease during the outbreak of Coronavirus Disease 2019

Yu M, Ye Z, Chen Y, Qin T, Kou J, Tian D, Xiao F.

Abstract:

Link to Article

The Risk of Respiratory Tract Infections in Psoriasis Patients Treated With IL-23-pathway Inhibiting Biologics: A Meta-Estimate of Pivotal Trials Relevant to Decision-Making During the COVID-19 Pandemic

Syed MN, Shin DB, Wan MT, Winthrop KL, Gelfand JM.

Abstract:

Link to Article

THE COURAGE TO RETURN TO EVERYDAY LIFE AT THE TIME OF COVID-19: THE POINT OF VIEW OF INFLAMMATORY BOWEL DISEASE PATIENTS NEEDING ENDOSCOPY

Mocciaro F, Scimeca D, Di Mitri R.

Abstract:

Link to Article

New data emerging on outcomes for patients with COVID-19 and rheumatic diseases

Onuora S.

Abstract:

Link to Article

Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study

Della-Torre E, Campochiaro C, Cavalli G, De Luca G, Napolitano A, La Marca S, Boffini N, Da Prat V, Di Terlizzi G, Lanzillotta M, Rovere Querini P, Ruggeri A, Landoni G, Tresoldi M, Ciceri F, Zangrillo A, De Cobelli F, Dagna L; SARI-RAF Study Group; SARI-RAF Study Group members.

Abstract:

Link to Article

Challenges for Management of Immune Thrombocytopenia during COVID-19 Pandemic

Sahu KK, Siddiqui AD, Rezaei N, Cerny J.

Abstract:

Link to Article

Reply to the Letter to the Editor: The Incidence and Outcomes of COVID-19 in Patients With IBD: A Rapid Review and Meta-Analysis

Burgueño JF, Abreu MT.

Abstract:

Link to Article

Review of Societal Recommendations Regarding Management of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic

Grossberg LB, Pellish RS, Cheifetz AS, Feuerstein JD.

Abstract:

Link to Article

The Incidence and Outcomes of COVID-19 in IBD Patients: A Rapid Review and Meta-analysis

Aziz M, Fatima R, Haghbin H, Lee-Smith W, Nawras A.

Abstract:

Link to Article

Should We Be Screening for SARS-CoV-2 in IBD Patients Before Initiation of Biologic Therapy?

Hashash JG, Jabak S, Francis FF, Regueiro M.

Abstract:

Link to Article

COVID-19 patients with psoriasis and psoriatic arthritis on biologic immunosuppressant therapy versus apremilast in North Spain

Queiro Silva R, Armesto S, Gonz√°lez Vela C, Naharro Fern√°ndez C, Gonz√°lez-Gay MA.

Abstract:

Link to Article

The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center

Lopetuso LR, Scaldaferri F, Ianiro G, Bibbò S, Settanni CR, Papa A, Armuzzi A, Gasbarrini A, Cammarota G.

Abstract:

Link to Article

Concerns and needs of patients with systemic lupus erythematosus regarding hydroxychloroquine supplies during the COVID-19 pandemic: results from a patient-centred survey

Plüß M, Chehab G, Korsten P.

Abstract:

Link to Article

Response to: 'Concerns and needs of patients with systemic lupus erythematosus regarding hydroxychloroquine supplies during the COVID-19 pandemic: results from a patient-centred survey' by Plüß et al

Mathian A, Amoura Z.

Abstract:

Link to Article

Angiotensin-converting enzyme 2, a SARS-CoV-2 receptor, is upregulated by interleukin-6 via STAT3 signaling in synovial tissues

Mokuda S, Tokunaga T, Masumoto J, Sugiyama E.

Abstract:

Link to Article

COVID-19 and the practice of rheumatology in Africa: big changes to services from the shockwave of a pandemic

Akintayo RO, Akpabio A, Kalla A, Dey D, Migowa A, Olaosebikan H, Bahiri R, El Miedany Y, Hadef D, Hamdi W, Oyoo O, Slimani S, Yerima A, Taha Y, Adebajo A, Adelowo O, Tikly M, Ghozlani I, Abdelghani KB, Fouad NA, Mosad D, El Mikkawy D, Abu-Zaid MH, Abdel-Magied RA; COVID-19 African Rheumatology Study Group.

Abstract:

Link to Article

Lupus anticoagulant is frequent in patients with Covid-19: Response to Reply

Harzallah I, Debliquis A, Drénou B.

Abstract:

Link to Article

Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases

Nuño L, Novella Navarro M, Bonilla G, Franco-Gómez K, Aguado P, Peiteado D, Monjo I, Tornero C, Villalba A, Miranda-Carus ME, De Miguel E, Bogas P, Castilla-Plaza A, Bernad-Pineda M, García-Lorenzo E, Rodríguez-Araya T, Balsa A.

Abstract:

Link to Article

Response to: 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis' by Györfi et al

Gianfrancesco M, Hyrich KL, Yazdany J, Machado PM, Robinson PC.

Abstract:

Link to Article

Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis

Györfi AH, Kopp M, May M, Vetter M, Uder M, Kremer AE, Schett G, Harrer T, Distler JHW.

Abstract:

Link to Article

A balanced approach to decision-making in supporting people with IDD in extraordinarily challenging times

Luckasson R, Schalock RL.

Abstract:

Link to Article

Managing an IBD Infusion Unit During the COVID-19 Pandemic: Service Modifications and the Patient Perspective

Clough JN, Hill KL, Duff A, Sharma E, Ray S, Mawdsley JE, Anderson S, Irving PM, Samaan MA.

Abstract:

Link to Article

Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review

Coskun Benlidayi I, Kurtaran B, Tirasci E, Guzel R.

Abstract:

Link to Article

Clinical course and outcome of COVID-19 in patients with rheumatic diseases: are all biological disease-modifying antirheumatic drugs alike? Response to: 'Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab' by Schulze-Koops et al

Monti S, Montecucco C.

Abstract:

Link to Article

Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab

Schulze-Koops H, Krueger K, Vallbracht I, Hasseli R, Skapenko A.

Abstract:

Link to Article

Zero COVID-19 infection in inflammatory bowel disease patients: Findings from National IBD Registries in Hong Kong and Taiwan

Mak JWY, Weng MT, Wei SC, Ng SC.

Abstract:

Link to Article

COVID-19 and rheumatology: is shielding really necessary?

Amani L, Warraich R, Patel N, Tahir H.

Abstract:

Link to Article

Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic

Soy M, Atagündüz P, Atagündüz I, Sucak GT.

Abstract:

Link to Article

Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors

Jovani V, Calabuig I, Peral-Garrido ML, Tovar-Sugrañes E, López-González MD, Bernabeu P, Martínez A, Esteve-Vives J, León-Ramírez JM, Moreno-Perez O, Boix V, Gil J, Merino E, Vela P, Andrés M.

Abstract:

Link to Article

Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments

Gendebien Z, von Frenckell C, Ribbens C, André B, Thys M, Gangolf M, Seidel L, Malaise MG, Malaise O.

Abstract:

Link to Article

Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic

Santos-Moreno P, Chavez-Chavez J, Hernández-Zambrano SM, Rivera-Triana DP, Castiblanco-Montañez RA, Aza A, Buitrago-Garcia D, Villarreal L, Rojas-Villarraga A.

Abstract:

Link to Article

Response to: 'Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors' by Jovani et al

D'Silva KM, Serling-Boyd N, Wallwork R, Hsu T, Sparks JA, Wallace ZS.

Abstract:

Link to Article

Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics

Mendel A, Bernatsky S, Askanase A, Bae SC, Clarke AE, Costedoat-Chalumeau N, Gladman DD, Gordon C, Hanly J, Jacobsen S, Kalunian K, Mak A, Mosca M, Pons-Estel BA, Ruiz-Irastorza G, Urowitz M, Vinet É.

Abstract:

Link to Article

Response to: 'Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic' by Santos-Moreno et al

Bozzalla Cassione E, Zanframundo G, Biglia A, Codullo V, Montecucco C, Cavagna L.

Abstract:

Link to Article

Rheumatology practice amidst the COVID-19 pandemic: a pragmatic view

Rom√£o VC, Cordeiro I, Macieira C, Oliveira-Ramos F, Romeu JC, Rosa CM, Saavedra MJ, Saraiva F, Vieira-Sousa E, Fonseca JE.

Abstract:

Link to Article

Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2-exploring RAS inhibitors-authors' reply

Taxonera C, Sagastagoitia I, Alba C, Mañas N, Olivares D, Rey E.

Abstract:

Link to Article

Stopping Clinical Trials in Inflammatory Bowel Disease During the COVID-19 Pandemic is not a Responsible Act

Schreiber S, Dignass A, Rogge A, Rubin DT.

Abstract:

Link to Article

An urgent need to institute COVID-19 testing in patients with IBD experiencing flares

Quraishi MN, Cooney R, Brookes MJ, Sharma N.

Abstract:

Link to Article

Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19

Vlachoyiannopoulos PG, Magira E, Alexopoulos H, Jahaj E, Theophilopoulou K, Kotanidou A, Tzioufas AG.

Abstract:

Link to Article

Patient acceptance of using telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak

So H, Szeto CC, Tam LS.

Abstract:

Link to Article

Telemedicine holds many promises but needs to be developed to be accepted by patients as an alternative to a visit to the doctor. Response to: 'Patient acceptance of using telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak' by So et al

Schulze-Koops H, Specker C, Krueger K.

Abstract:

Link to Article

From the American Epicenter: Coronavirus Disease 2019 in Patients with Inflammatory Bowel Disease in the New York City Metropolitan Area

Axelrad JE, Malter L, Hong S, Chang S, Bosworth B, Hudesman D.

Abstract:

Link to Article

Treatment adherence behaviours in rheumatic diseases during COVID-19 pandemic: a Latin American experience

Pineda-Sic RA, Galarza-Delgado DA, Serna-Peña G, Castillo-Torres SA, Flores-Alvarado DE, Esquivel-Valerio JA, Hernández-Galarza IJ.

Abstract:

Link to Article

Actions required to assure continuous supply of anti-rheumatic medication during the SARS-CoV-2/COVID-19 pandemic. Response to: 'Treatment adherence behaviours in rheumatic diseases during pandemic COVID-19: a Latin American experience' by Pineda-Sic et al

Schulze-Koops H, Krueger K, Specker C; Kommission Pharmakotherapie of the German Society of Rheumatology.

Abstract:

Link to Article

Adherence of infusible biologics during the time of COVID-19 among patients with Inflammatory Bowel Disease: A nationwide VA cohort study

Khan N, Patel D, Xie D, Pernes T, Lewis J, Yang YX.

Abstract:

Link to Article

The psychological state and changes in the routine of the patients with rheumatic diseases during the coronavirus disease (COVID-19) outbreak in Turkey: a web-based cross-sectional survey

Seyahi E, Poyraz BC, Sut N, Akdogan S, Hamuryudan V.

Abstract:

Link to Article

Still early to define a clear role of antimalarial drugs for COVID-19 in patients with rheumatic disease. Response to: 'Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?' by Xie et al

Gamboa-Alonso CM, Figueroa-Parra G, Galarza-Delgado DA.

Abstract:

Link to Article

Psoriasis and COVID-19: a multifactorial consideration

Cohen JM, Perez-Chada LM, De Kouchkovsky D, Gehlhausen JR.

Abstract:

Link to Article

Clinical management of psoriasis patients during the COVID-19 pandemic

Chat VS, Uppal SK, Kearns DG, Wu JJ.

Abstract:

Link to Article

A cross-sectional survey on the psychological impact of the COVID-19 pandemic on inflammatory bowel disease patients in Saudi Arabia

Mosli M, Alourfi M, Alamoudi A, Hashim A, Saadah O, Al Sulais E, AlAmeel T, Alharbi O, Bakari S, Meeralam Y, Alshobai S, Alsahafi M, Jawa H, Qari Y.

Abstract:

Link to Article

COVID-19: Overview of Rheumatology Fellows

Garcia-Guillén A, Jeria S, Lobo-Prat D, Sainz L.

Abstract:

Link to Article

Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19

Fougerousse AC, Perrussel M, Bécherel PA, Begon E, Pallure V, Zaraa I, Chaby G, Parier J, Kemula M, Mery-Bossard L, Poreaux C, Taieb C, Maccari F, Reguiai Z; GEM Resopso.

Abstract:

Link to Article

Inflammatory Bowel Disease in the COVID-19 Pandemic - the Patients' Perspective

Grunert PC, Reuken PA, Stallhofer J, Teich N, Stallmach A.

Abstract:

Link to Article

Autoinflammatory and autoimmune conditions at the crossroad of COVID-19

Rodríguez Y, Novelli L, Rojas M, De Santis M, Acosta-Ampudia Y, Monsalve DM, Ramírez-Santana C, Costanzo A, Ridgway WM, Ansari AA, Gershwin ME, Selmi C, Anaya JM.

Abstract:

Link to Article

A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab

Cai S, Sun W, Li M, Dong L.

Abstract:

Link to Article

COVID-19 revisiting inflammatory pathways of arthritis

Schett G, Manger B, Simon D, Caporali R.

Abstract:

Link to Article

Mounting data indicate that antimalarials do not prevent mild or severe COVID-19 in rheumatic patients. Response to: 'The role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients' by Favalli et al

Rom√£o VC, Cruz-Machado AR, Fonseca JE.

Abstract:

Link to Article

Role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients

Favalli EG, De Lucia O, Biggioggero M, Del Papa N, Caporali R.

Abstract:

Link to Article

Challenges and opportunities in telerheumatology in the COVID-19 era. Response to: 'Online management of rheumatoid arthritis during COVID-19 pandemic' by Zhang et al

Figueroa-Parra G, Gamboa-Alonso CM, Galarza-Delgado DA.

Abstract:

Link to Article

''Treatment adherence in psoriatic patients during COVID-19 pandemic: Real-world data from a tertiary hospital in Greece''

Vakirlis AE, Bakirtzi K, Papadimitriou I, Vrani F, Sideris N, Lallas A, Ioannides D, Sotiriou E.

Abstract:

Link to Article

Complicated coronavirus disease 2019 (COVID-19) in a psoriatic patient treated with ixekizumab

Facheris P, Valenti M, Pavia G, Gargiulo L, Narcisi A, Costanzo A, Borroni RG.

Abstract:

Link to Article

SEVERE IBD FLARES AND COVID-19: EXPAND THE GASTROENTEROLOGY-SURGERY TEAM TO INCLUDE AN INFECTIOUS DISEASE SPECIALIST

Bezzio C, Saibeni S.

Abstract:

Link to Article

Impact of medication discontinuation on patients with inflammatory bowel disease during the COVID-19 outbreak

Chen J, Peng X, Zhang M, Zhi M.

Abstract:

Link to Article

Prevention of COVID-19 in patients with IBD - Authors' reply

Ding NS, An P, Dong W, Ding Y.

Abstract:

Link to Article

COVID-19 in patients with rheumatological diseases treated with anti-TNF

Brito CA, Paiva JG, Pimentel FN, Guimar√£es RS, Moreira MR.

Abstract:

Link to Article

Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China 'hot pot' versus in US 'hot pot': similarity and difference

Zhao J, Pang R, Wu J, Guo Y, Yang Y, Zhang L, Xia X.

Abstract:

Link to Article

Response to: 'COVID-19 in patients with rheumatological diseases treated with Anti-TNF' by Brito et al and 'Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China 'hot pot' versus in US 'hot pot': similarity and difference' by Zhao et al

D'Silva KM, Serling-Boyd N, Wallwork R, Hsu T, Sparks JA, Wallace ZS.

Abstract:

Link to Article

Clinical characteristics of 17 patients with COVID-19 and systemic autoimmune diseases: a retrospective study

Huang Y, Chen Z, Wang Y, Han L, Qin K, Huang W, Huang Y, Wang H, Shen P, Ba X, Lin W, Dong H, Zhang M, Tu S.

Abstract:

Link to Article

Psoriasis and risk of the COVID-19 infection: Is there a role for Angiotensin Converting Enzyme (ACE)?

Shahidi-Dadras M, Tabary M, Robati RM, Araghi F, Dadkhahfar S.

Abstract:

Link to Article

COVID-19 infection associated with autoimmune hemolytic anemia

Capes A, Bailly S, Hantson P, Gerard L, Laterre PF.

Abstract:

Link to Article

[Effectiveness of the contingency plan of the internal inflammatory disease unit before Covid-19 infection.]

Carpio López D, Martínez Pillado M, Salgado Barreira Á, Daponte Angueira S, Díez Lage R, Castro Ortiz E, Fernández Salgado E, Pérez Galindo P, Turnes Vázquez J.

Abstract:

Link to Article

Immune monitoring of a child with autoimmune hepatitis and type 1 diabetes during COVID-19 infection

Yuksel M, Akturk H, Arikan C.

Abstract:

Link to Article

Aspects of inflammatory bowel disease during the COVID-19 pandemic and general considerations

de León-Rendón JL, Hurtado-Salazar C, Yamamoto-Furusho JK.

Abstract:

Link to Article

Comment on "Psoriasis, COVID-19 and acute respiratory distress syndrome: focusing on the risk of concomitant biological treatment"

Farabi B, Bhargava S, Goldust M, Atak MF.

Abstract:

Link to Article

Molecular mimicry may explain multi-organ damage in COVID-19

Angileri F, Legare S, Gammazza AM, de Macario EC, Macario AJL, Cappello F.

Abstract:

Link to Article

Covid-19 and autoimmunity

Ehrenfeld M, Tincani A, Andreoli L, Cattalini M, Greenbaum A, Kanduc D, Alijotas-Reig J, Zinserling V, Semenova N, Amital H, Shoenfeld Y.

Abstract:

Link to Article

Cutaneous autoimmune diseases during COVID 19 pandemic

Günther C, Aschoff R, Beissert S.

Abstract:

Link to Article

Targeting the immunology of coronavirus disease-19: synchronization creates symphony

Ahmed S, Anirvan P.

Abstract:

Link to Article

Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases

Pablos JL, Abasolo L, Alvaro-Gracia JM, Blanco FJ, Blanco R, Castrejón I, Fernandez-Fernandez D, Fernandez-Gutierrez B, Galindo-Izquierdo M, Gonzalez-Gay MA, Manrique-Arija S, Mena Vázquez N, Mera Varela A, Retuerto M, Seijas-Lopez A.

Abstract:

Link to Article

Inflammatory Bowel Disease and COVID-19-"Preventive" Sick Certificates as a Frequent Coping Strategy in the Face of the Pandemic

Schlabitz F, Teich N, Michl P, Walldorf J.

Abstract:

Link to Article

How did COVID-19 pandemic changed the Portuguese rheumatology?

Vieira-Sousa E, Fonseca JE, Santos MJ.

Abstract:

Link to Article

SFED recommendations for IBD endoscopy during COVID-19 pandemic: Italian and French experience

Furfaro F, Vuitton L, Fiorino G, Koch S, Allocca M, Gilardi D, Zilli A, D'Amico F, Radice S, Chevaux JB, Schaefer M, Chaussade S, Danese S, Peyrin-Biroulet L.

Abstract:

Link to Article

Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort

Pouletty M, Borocco C, Ouldali N, Caseris M, Basmaci R, Lachaume N, Bensaid P, Pichard S, Kouider H, Morelle G, Craiu I, Pondarre C, Deho A, Maroni A, Oualha M, Amoura Z, Haroche J, Chommeloux J, Bajolle F, Beyler C, Bonacorsi S, Carcelain G, Koné-Paut I, Bader-Meunier B, Faye A, Meinzer U, Galeotti C, Melki I.

Abstract:

Link to Article

Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort

Costa L, Tasso M, Scotti N, Mostacciuolo E, Girolimetto N, Foglia F, Del Puente A, Scarpa R, Caso F.

Abstract:

Link to Article

Response to: 'Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort' by Costa et al

Gupta L, Misra DP, Agarwal V, Balan S, Agarwal V.

Abstract:

Link to Article

Digital crowdsourcing: unleashing its power in rheumatology

Krusche M, Burmester GR, Knitza J.

Abstract:

Link to Article

SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients

Zen M, Fuzzi E, Astorri D, Saccon F, Padoan R, Ienna L, Cozzi G, Depascale R, Zanatta E, Gasparotto M, Benvenuti F, Bindoli S, Gatto M, Felicetti M, Ortolan A, Campaniello D, Larosa M, Lorenzin M, Ramonda R, Sfriso P, Schiavon F, Iaccarino L, Doria A.

Abstract:

Link to Article

Screening for active COVID-19 infection prior to biologic therapy in IBD patients: Let's not increase our uncertainty without reducing our concerns

Festa S, Aratari A, De Biasio F, Fascì-Spurio F, Papi C.

Abstract:

Link to Article

Fecal Calprotectin and RT-PCR from both nasopharyngeal swab and stool samples prior to treatment decision in IBD patients during CoVID-19 outbreak

Younes C.

Abstract:

Link to Article

Perspectives of patients with rheumatic diseases in the early phase of COVID-19

Antony A, Connelly K, De Silva T, Eades L, Tillett W, Ayoub S, Morand E.

Abstract:

Link to Article

COVID-19 era: A chance to learn something new about monitoring psoriatic patients in biological therapy

Filippi F, Loi C, Evangelista V, Bardazzi F.

Abstract:

Link to Article

Biologics, spondylitis and COVID-19

Rosenbaum JT, Hamilton H, Choi D, Weisman MH, Reveille JD, Winthrop KL.

Abstract:

Link to Article

Covid-19 and inflammatory bowel disease: questions on incidence, severity, and impact of treatment?

Caron B, Arondel Y, Reimund JM.

Abstract:

Link to Article

Risk of Severe COVID-19 in Patients with Inflammatory Bowel Disease in United States. A Multicenter Research Network Study

Singh S, Khan A, Chowdhry M, Bilal M, Kochhar GS, Clarke K.

Abstract:

Link to Article

Managing Psoriasis Consultations During the COVID-19 Pandemic: Recommendations from the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (AEDV)

Belinchón I, Puig L, Ferrándiz L, De La Cueva P, Carrascosa JM; en nombre del Grupo de Psoriasis de la AEDV.

Abstract:

Link to Article

Safety of drugs during previous and current coronavirus pandemics: Lessons for IBD

Sebastian S, Gonzalez HA, Peyrin-Biroulet L.

Abstract:

Link to Article

Clinical trials for inflammatory bowel disease: a global guidance during COVID-19 pandemic

Reinisch W, Danese S, Peyrin-Biroulet L, Loftus EV.

Abstract:

Link to Article

A COVID-19 pneumonia case report of autoimmune polyendocrine syndrome type 1 in Lombardy, Italy: letter to the editor

Beccuti G, Ghizzoni L, Cambria V, Codullo V, Sacchi P, Lovati E, Mongodi S, Iotti GA, Mojoli F.

Abstract:

Link to Article

Rheumatologists rapidly adjust patient care during COVID-19 pandemic

Kirby T.

Abstract:

Link to Article

Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases

Dos Reis Neto ET, Kakehasi AM, de Medeiros Pinheiro M, Ferreira GA, Marques CDL, da Mota LMH, Dos Santos Paiva E, Pileggi GCS, Sato EI, Reis APMG, Xavier RM, Provenza JR.

Abstract:

Link to Article

Temporal Improvement of a COVID-19-Positive Crohn's Disease Patient Treated With Bismuth Subsalicylate

Wolf DC, Wolf CH, Rubin DT.

Abstract:

Link to Article

[The treatment of inflammatory bowel disease during the SARS-CoV-2 epidemic – practical advices: (A COVID–19-pandémia orvosszakmai kérdései)]

Resál T, Rutka M, Szántó K, Farkas K, Molnár T.

Abstract:

Link to Article

Covid-19: Was Rheumapatienten jetzt wissen sollten : Handlungsempfehlungen der DGRh

Kraus D.

Abstract:

Link to Article

Management of pediatric rheumatic patients in Kazakhstan during the coronavirus disease 2019 (COVID-19) pandemic

Mukusheva Z, Assylbekova M, Poddighe D.

Abstract:

Link to Article

Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID-19 pandemic

Ling KL, Hilmi I, Raja Ali RA, Leong RWL, Leung WK, Ng SC, Wu KC, Chen MH, Ran ZH, Hisamatsu T, Ahuja V, Makharia GK, Banerjee R, Wei SC, Wu DC, Pisespongsa P, Ye BD, Sollano J, Simadibrata M, Chuah SW, Ooi CJ.

Abstract:

Link to Article

Rheumatologists and Pulmonologists at Temple University weather the COVID-19 storm together

Caricchio R, Criner GJ.

Abstract:

Link to Article

Teamwork, A Novel Concept During an Infectious Pandemic?

Cron RQ, Chatham WW.

Abstract:

Link to Article

Response to: 'Monitoring of patients with systemic lupus erythematosus during the COVID-19 outbreak' by Holubar et al

Mathian A, Amoura Z.

Abstract:

Link to Article

Monitoring of patients with systemic lupus erythematosus during the COVID-19 outbreak

Holubar J, Le Quintrec M, Letaief H, Faillie JL, Pers YM, Jorgensen C.

Abstract:

Link to Article

COVID-19 in rheumatic disease patients on immunosuppressive agents

Sharmeen S, Elghawy A, Zarlasht F, Yao QP.

Abstract:

Link to Article

Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients

Sawalha AH, Zhao M, Coit P, Lu Q.

Abstract:

Link to Article

Critically ill SARS-CoV-2 patients display lupus-like hallmarks of extrafollicular B cell activation

Woodruff M, Ramonell R, Cashman K, Nguyen D, Ley A, Kyu S, Saini A, Haddad N, Chen W, Howell JC, Ozturk T, Lee S, Estrada J, Morrison-Porter A, Derrico A, Anam F, Wu H, Le S, Jenks S, Hu W, Lee FE, Sanz I.

Abstract:

Link to Article

Reduced expression of COVID-19 host receptor, ACE2 is associated with small bowel inflammation, more severe disease, and response to anti-TNF therapy in Crohn's disease

Potdar AA, Dube S, Naito T, Botwin G, Haritunians T, Li D, Yang S, Bilsborough J, Denson LA, Daly M, Targan SR, Fleshner P, Braun J, Kugathasan S, Stappenbeck TS, McGovern DPB.

Abstract:

Link to Article

COVID-19 and Its Potential Effect on Patients With Rheumatic Diseases in Latin America

Elera-Fitzcarrald C, Ugarte-Gil MF, Alarcón GS.

Abstract:

Link to Article

Status of a real-life cohort of patients with moderate-to-severe plaque psoriasis treated with secukinumab and considerations on the use of biological agents in the Covid-19 era

Galluzzo M, Tofani L, Bianchi L, Talamonti M.

Abstract:

Link to Article

Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data?

Favalli EG, Monti S, Ingegnoli F, Balduzzi S, Caporali R, Montecucco C.

Abstract:

Link to Article

Cutaneous lupus erythematosus patients in a high-epidemic COVID-19 area, Bergamo, Italy

Vezzoli P, Di Mercurio M, Carugno A, Gambini DM, Robustelli Test E, Imberti G, Castagna AF, Sena P.

Abstract:

Link to Article

Adopting PROs in virtual and outpatient management of RA

Taylor PC.

Abstract:

Link to Article

COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases

López-Medina C, Escudero A, Collantes-Estevez E.

Abstract:

Link to Article

Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies

Sanchez-Piedra C, Diaz-Torne C, Manero J, Pego-Reigosa JM, Rúa-Figueroa Í, Gonzalez-Gay MA, Gomez-Reino J, Alvaro-Gracia JM; BIOBADASER study group.

Abstract:

Link to Article

Telemedicine: a useful tool but not the holy grail. Response to: 'Telemedicine will not keep us apart in the COVID-19 pandemic' by Perniola et al

Bozzalla Cassione E, Zanframundo G, Biglia A, Codullo V, Montecucco C, Cavagna L.

Abstract:

Link to Article

Candidate rheumatologic treatments for COVID-19. Response to: 'COVID-19 infection in a patient with FMF: does colchicine have a protective effect?' by Kobak

Monti S, Montecucco C.

Abstract:

Link to Article

EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2

Landewé RB, Machado PM, Kroon F, Bijlsma HW, Burmester GR, Carmona L, Combe B, Galli M, Gossec L, Iagnocco A, Isaacs JD, Mariette X, McInnes I, Mueller-Ladner U, Openshaw P, Smolen JS, Stamm TA, Wiek D, Schulze-Koops H.

Abstract:

Link to Article

COVID-19 infection in a patient with FMF: does colchicine have a protective effect?

Kobak S.

Abstract:

Link to Article

Telemedicine will not keep us apart in COVID-19 pandemic

Perniola S, Alivernini S, Varriano V, Paglionico A, Tanti G, Rubortone P, Lanzo L, Melpignano F, Tur C, De Lorenzis E, Peluso G, Capacci A, Gremese E.

Abstract:

Link to Article

Response to: 'COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases' by Lopez-Medina et al

Bozzalla Cassione E, Zanframundo G, Biglia A, Codullo V, Montecucco C, Cavagna L.

Abstract:

Link to Article

Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab

Avouac J, Airó P, Carlier N, Matucci-Cerinic M, Allanore Y.

Abstract:

Link to Article

Response to: 'Severe COVID-19 associated pneumonia in 3 patients with systemic sclerosis treated with rituximab' by Avouac et al

Guilpain P, Le Bihan C, Foulongne V, Taourel P, Pansu N, Maria ATJ, Jung B, Larcher R, Klouche K, Le Moing V.

Abstract:

Link to Article

The association between severe or death COVID-19 and autoimmune disease: a systematic review and meta-analysis

Liu M, Gao Y, Zhang Y, Shi S, Chen Y, Tian J.

Abstract:

Link to Article

Rheumatic diseases during pregnancy and SARS-CoV-2: An appeal for medication adherence

Scioscia M, Praino E, Scioscia C.

Abstract:

Link to Article

Psoriasis-COVID 19 Infection: Treatment Options

Tampouratzi E, Kanni T, Katsantonis J, Douvali T.

Abstract:

Link to Article

Implications of COVID-19 in pediatric rheumatology

Batu ED, Özen S.

Abstract:

Link to Article

Severe exacerbation of immune thrombocytopenia and COVID-19: the favorable response to corticosteroid-based therapy-a case report

Hu Z, Chen W, Liang W, Xu C, Sun W, Yi Y.

Abstract:

Link to Article

Autoimmune and inflammatory diseases following COVID-19

Galeotti C, Bayry J.

Abstract:

Link to Article

Combination of thrombolytic and immunosuppressive therapy for coronavirus disease 2019: A case report

Papamichalis P, Papadogoulas A, Katsiafylloudis P, Skoura AL, Papamichalis M, Neou E, Papadopoulos D, Karagiannis S, Zafeiridis T, Babalis D, Komnos A.

Abstract:

Link to Article

Author´s answer to: "Effect of adacolumn® in ulcerative colitis with COVID-19"

Hinojosa Del Val J, Crespo J, Pérez-Cuadrado Martínez E.

Abstract:

Link to Article

The effect of Adacolumn® on ulcerative colitis with COVID-19

Pérez Roldán F, Bernardos Martín ME, González Carro P.

Abstract:

Link to Article

Recommendations for Treatment of Nail Psoriasis During the COVID-19 Pandemic

Ricardo JW, Lipner SR.

Abstract:

Link to Article

Management of COVID-19 Pandemic in Spanish Inflammatory Bowel Disease Units: Results From a National Survey

Martin Arranz E, Suarez Ferrer C, García Ramírez L, Rueda García JL, Sánchez-Azofra M, Poza Cordón J, Noci J, Zabana Y, Barreiro-de Acosta M, Martín-Arranz MD.

Abstract:

Link to Article

COVID-19 presenting with autoimmune hemolytic anemia in the setting of underlying immune dysregulation

Wahlster L, Weichert-Leahey N, Trissal M, Grace RF, Sankaran VG.

Abstract:

Link to Article

COVID-19 in rheumatology outpatient clinics: Dutch mirror image to Lombardy, Italy

Benoy S, Traksel R, Verhaegh P, Broen J.

Abstract:

Link to Article

Self-care recommendations for patients with rheumatic diseases during the COVID-19 pandemic

Kim HS, Lee MS, Kim H, Sung YK, Lee J, Shim SC, Park SH, Baek HJ.

Abstract:

Link to Article

Cranial Neuropathies and COVID-19: Neurotropism and Autoimmunity

Costello F, Dalakas MC.

Abstract:

Link to Article

The day after COVID-19 in IBD: how to go back to 'normal'

Danese S, Sands B, Ng SC, Peyrin-Biroulet L.

Abstract:

Link to Article

Are patients with systemic lupus erythematosus at increased risk of severe COVID-19?

Favalli EG, Agape E, Caporali R.

Abstract:

Link to Article

No SLE with COVID-19 in Hong Kong: the effect of masking?

So H, Mak JWY, Tam LS.

Abstract:

Link to Article

Implementing telemedicine in inflammatory bowel disease: Is COVID-19 the definitive trigger?

Del Hoyo J, Aguas M.

Abstract:

Link to Article

Rates of symptomatic SARS-CoV-2 infection in patients with autoimmune liver diseases in Northern Italy: a telemedicine study

Rigamonti C, Cittone MG, De Benedittis C, Rizzi E, Casciaro GF, Bellan M, Sainaghi PP, Pirisi M.

Abstract:

Link to Article

Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients with Inflammatory Bowel Disease

Lukin DJ, Kumar A, Hajifathalian K, Sharaiha RZ, Scherl EJ, Longman RS; JRC Study Group; WCM-GI Study Group.

Abstract:

Link to Article

Psoriatic Arthritis and COVID-19 Pandemic: Consequences in Medical Treatment?

Wollina U, Fioranelli M, Goldust M, Lotti T.

Abstract:

Link to Article

Covid-19 infection in psoriasis patients treated with cyclosporin

Di Lernia V, Goldust M, Feliciani C.

Abstract:

Link to Article

Psoriasis, biologic therapy, and the pandemic of the 21st century

Nogueira M, Vender R, Torres T.

Abstract:

Link to Article

Olfactory and Gustatory Dysfunction in a COVID-19 Patient with Ankylosing Spondylitis Treated with Etanercept: Case Report

Lee JM, Lee SJ.

Abstract:

Link to Article

The Greek Response to COVID-19: A True Success Story from an IBD Perspective

Bamias G, Lagou S, Gizis M, Karampekos G, Kyriakoulis KG, Pontas C, Mantzaris GJ.

Abstract:

Link to Article

Patients with lupus with COVID-19: University of Michigan experience

Wallace B, Washer L, Marder W, Kahlenberg JM.

Abstract:

Link to Article

Patients with systemic lupus erythematosus using hydroxychloroquine or chloroquine develop severe COVID-19 at similar frequency as patients not on antimalarials: need to explore antithrombotic benefits for COVID-19 coagulopathy. Response to: 'Clinical course of COVID-19 in patients with systemic

Konig MF, Gianfrancesco M, Yazdany J, Robinson PC.

Abstract:

Link to Article

No advice to discontinue antirheumatic therapy for non-medical reasons in light of SARS-CoV-2. Response to: 'Treatment adherence of patients with sytemic rheumatic diseases in COVID-19 pandemic' by Fragoulis et al

Schulze-Koops H, Krueger K, Specker C.

Abstract:

Link to Article

Response to: 'Patients with lupus with COVID-19: University of Michigan experience' by Wallace et al

Mathian A, Amoura Z.

Abstract:

Link to Article

Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine

Carbillon L, Benbara A, Boujenah J.

Abstract:

Link to Article

Treatment adherence of patients with systemic rheumatic diseases in COVID-19 pandemic

Fragoulis GE, Evangelatos G, Arida A, Bournia VK, Fragiadaki K, Karamanakos A, Kravvariti E, Laskari K, Panopoulos S, Pappa M, Tektonidou MG, Sfikakis PP.

Abstract:

Link to Article

Rate of Patient-Driven Biologic Treatment Discontinuation During the COVID-19 Pandemic in 2 Academic Hospital Clinics at the University of Toronto

Georgakopoulos JR, Yeung J.

Abstract:

Link to Article

Patterns of endoscopy during COVID-19 pandemic: a global survey of interventional inflammatory bowel disease practice

Chen Y, Yu Q, Farraye FA, Kochhar GS, Bernstein CN, Navaneethan U, Wu K, Zhong J, Schwartz DA, Wu H, Zheng JJ, Iacucci M, Kiran RP, Shen B.

Abstract:

Link to Article

Psoriasis, COVID-19 and acute respiratory distress syndrome: focusing on the risk of concomitant biological treatment

Magnano M, Balestri R, Bardazzi F, Mazzatenta C, Girardelli CR, Rech G.

Abstract:

Link to Article

Potential role of Anti-IL-17 in COVID-19 treatment

Ayhan E, Öztürk M, An İ, Abdelmaksoud A, Araç E.

Abstract:

Link to Article

Clinical efficacy, speed of improvement and safety of apremilast for the treatment of adult Psoriasis during COVID-19 pandemic

Melis D, Mugheddu C, Sanna S, Atzori L, Rongioletti F.

Abstract:

Link to Article

Non-complicated evolution of COVID-19 infection in a patient with psoriasis and psoriatic arthritis during treatment with adalimumab

Valenti M, Facheris P, Pavia G, Gargiulo L, Borroni RG, Costanzo A, Narcisi A.

Abstract:

Link to Article

Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19?

Vakil-Gilani K, O'Rourke K.

Abstract:

Link to Article

Switching to teleconsultation for rheumatology in the wake of the COVID-19 pandemic: feasibility and patient response in India

Shenoy P, Ahmed S, Paul A, Skaria TG, Joby J, Alias B.

Abstract:

Link to Article

Innovation in IBD Care During the COVID-19 Pandemic: Results of a Global Telemedicine Survey by the International Organization for the Study of Inflammatory Bowel Disease

Lees CW, Regueiro M, Mahadevan U; International Organization for the Study of Inflammatory Bowel Disease.

Abstract:

Link to Article

Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient

Sagnelli C, Gentile V, Tirri R, Macera M, Cappabianca S, Ciccia F; Vanvitelli COVID-19 group.

Abstract:

Link to Article

Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020

Richez C, Flipo RM, Berenbaum F, Cantagrel A, Claudepierre P, Debiais F, Dieudé P, Goupille P, Roux C, Schaeverbeke T, Wendling D, Pham T, Thomas T.

Abstract:

Link to Article

COVID 19 and Ethnicity: Spot light on the global rheumatology issues in developing and developed countries

Moorthy A, Dubey S, Samanta A, Adebajo A, Aggarwal A, Jain A, Jain N, Lim SS, Kerr GS, Kumar K.

Abstract:

Link to Article

Potential inhibition of COVID-19-driven pneumonia by immunosuppressive therapy and anti-TNFα antibodies: a case report

Kunisaki R, Tsukiji J, Kudo M.

Abstract:

Link to Article

Rheumatology Care in the Face of COVID-19

Lubrano E, Scriffignano S, Perrotta FM.

Abstract:

Link to Article

COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments

Ouédraogo DD, Tiendrébéogo WJS, Kaboré F, Ntsiba H.

Abstract:

Link to Article

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L, Izadi Z, Jacobsohn L, Katz P, Lawson-Tovey S, Mateus EF, Rush S, Schmajuk G, Simard J, Strangfeld A, Trupin L, Wysham KD, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Wallace ZS, Yazdany J, Machado PM, Robinson PC; COVID-19 Global Rheumatology Alliance.

Abstract:

Link to Article

Response to: Correspondence regarding research letter to the editor by Mathian et al, 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'' by Nikpour et al

Mathian A, Amoura Z.

Abstract:

Link to Article

Case series of acute arthritis during COVID-19 admission

López-González MD, Peral-Garrido ML, Calabuig I, Tovar-Sugrañes E, Jovani V, Bernabeu P, García-Sevila R, León-Ramírez JM, Moreno-Perez O, Boix V, Gil J, Merino E, Vela P, Andrés M.

Abstract:

Link to Article

Correspondence regarding research letter to the editor by Mathian et al, 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'

Nikpour M, Teh B, Wicks IP, Pellegrini M.

Abstract:

Link to Article

Response to: 'Case series of acute arthritis in COVID-19 admission' by López-González et al

Graef ER, Liew JW, Kim AH, Sparks JA.

Abstract:

Link to Article

Frequency of lupus anticoagulant in Covid-19 patients

Harzallah I, Debliquis A, Drénou B.

Abstract:

Link to Article

Novel Coronavirus Disease (COVID-19) and Biologic Therapy for Psoriasis: Successful Recovery in Two Patients After Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Brownstone ND, Thibodeaux QG, Reddy VD, Myers BA, Chan SY, Bhutani T, Liao W.

Abstract:

Link to Article

Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study

Salvarani C, Bajocchi G, Mancuso P, Galli E, Muratore F, Boiardi L, Catanoso M, Pipitone N, Cassone G, Girolimetto N, Croci S, Cimino L, Gradellini F, Beltrami M, Di Lernia V, Dolci G, Massari M, Marata AM, Costantini M, Giorgi Rossi P.

Abstract:

Link to Article

Care for patients with rheumatic diseases during COVID-19 pandemic: A position statement from APLAR

Tam LS, Tanaka Y, Handa R, Chang CC, Cheng YK, Isalm N, Li M, Lorenzo JP, Song YW, Yamamoto K, Zeng X, Haq SA.

Abstract:

Link to Article

Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19

Albiol N, Awol R, Martino R.

Abstract:

Link to Article

Use of systemic therapies for psoriasis in the COVID-19 era

Kearns DG, Uppal S, Chat VS, Wu JJ.

Abstract:

Link to Article

Considerations for Safety in the Use of Systemic Medications for Psoriasis and Atopic Dermatitis during the COVID-19 pandemic

Ricardo JW, Lipner SR.

Abstract:

Link to Article

Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'

D'Silva KM, Serling-Boyd N, Wallwork R, Hsu T, Fu X, Gravallese EM, Choi HK, Sparks JA, Wallace ZS.

Abstract:

Link to Article

Two False Negative Test Results in a Symptomatic Patient with a Confirmed Case of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Suspected Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN)

Lagziel T, Quiroga L, Ramos M, Hultman CS, Asif M.

Abstract:

Link to Article

Pediatric Crohn's Disease and Multisystem Inflammatory Syndrome in Children (MIS-C) and COVID-19 Treated with Infliximab

Dolinger MT, Person H, Smith R, Jarchin L, Pittman N, Dubinsky MC, Lai J.

Abstract:

Link to Article

COVID-19: the new challenge for rheumatologists. First update

Ferro F, Elefante E, Puxeddu I, Baldini C, Bartoloni E, Baratè C, Galimberti S, Talarico R, Mosca M, Bombardieri S.

Abstract:

Link to Article

Understanding immune effects of oestrogens to explain the reduced morbidity and mortality in female versus male COVID-19 patients. Comparisons with autoimmunity and vaccination

Cutolo M, Smith V, Paolino S.

Abstract:

Link to Article

Treating Covid-19 at the Inflection Point

Chatham WW, Cron RQ.

Abstract:

Link to Article

Evidence of protective effect of hydroxychloroquine to prevent COVID-19

Joob B, Wiwanitkit V.

Abstract:

Link to Article

Dr. Balevic, et al, reply

Balevic SJ, Hornik CP, Green TP, Clowse MEB, Gonzalez D, Maharaj AR, Schanberg LE, Eudy AM, Swamy GK, Hughes BL, Cohen-Wolkowiez M.

Abstract:

Link to Article

Response to: 'Are patients with systemic lupus erythematosus at increased risk for COVID-19?' by Favalli et al

Mathian A, Amoura Z.

Abstract:

Link to Article

Are patients with systemic lupus erythematosus at increased risk for COVID-19?

Favalli EG, Gerosa M, Murgo A, Caporali R.

Abstract:

Link to Article

IBD in the Times of COVID-19

Hern√°ndez Benabe S, Langshaw AH.

Abstract:

Link to Article

Impact of delayed diagnoses at the time of COVID-19: increased rate of preventable bilateral blindness in giant cell arteritis

Monti S, Delvino P, Bellis E, Milanesi A, Brandolino F, Montecucco C.

Abstract:

Link to Article

YouTube as a source of information on COVID-19 and rheumatic disease link

Kocyigit BF, Akaltun MS, Sahin AR.

Abstract:

Link to Article

Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: a population-based study in the first two months of COVID-19 outbreak in Italy

Quartuccio L, Valent F, Pasut E, Tascini C, Vita S.

Abstract:

Link to Article

Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China

Ye C, Cai S, Shen G, Guan H, Zhou L, Hu Y, Tu W, Chen Y, Yu Y, Wu X, Chen Y, Zhong J, Dong L.

Abstract:

Link to Article

Telemedicine for Pediatric Inflammatory Bowel Disease in the Era of COVID-19

Verstraete SG, Sola AM, Ali SA.

Abstract:

Link to Article

Corona Virus Disease 2019 and Paediatric Inflammatory Bowel Diseases: Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology, and Nutrition

Turner D, Huang Y, Martín-de-Carpi J, Aloi M, Focht G, Kang B, Zhou Y, Sanchez C, Kappelman MD, Uhlig HH, Pujol-Muncunill G, Ledder O, Lionetti P, Dias JA, Ruemmele FM, Russell RK; Paediatric IBD Porto group of ESPGHAN.

Abstract:

Link to Article

Hydroxychloroquine effects on psoriasis: a systematic review and a cautionary note for COVID-19 treatment

Sachdeva M, Mufti A, Maliyar K, Lytvyn Y, Yeung J.

Abstract:

Link to Article

Prevention of COVID-19 in patients with IBD

Segal JP, Quraishi MN, Bhala N, Brookes MJ.

Abstract:

Link to Article

Protecting patients with IBD during the COVID-19 pandemic

Fiorino G, Peyrin-Biroulet L, Danese S.

Abstract:

Link to Article

A Rare Case of Immune Thrombocytopenic Purpura Secondary to COVID-19

Yang Y, Zhao J, Wu J, Teng Y, Xia X.

Abstract:

Link to Article

Should we be using the Covid-19 outbreak to prompt us to transform our rheumatology service delivery in the technology age?

Jethwa H, Abraham S.

Abstract:

Link to Article

Clinical and Psychological Issues in Children with Inflammatory Bowel Disease During COVID-19 Pandemic

Martinelli M, Strisciuglio C, Fedele F, Miele E, Staiano A.

Abstract:

Link to Article

Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience

Sun Y, Dong Y, Wang L, Xie H, Li B, Chang C, Wang FS.

Abstract:

Link to Article

Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre

Scaldaferri F, Pugliese D, Privitera G, Onali S, Lopetuso LR, Rizzatti G, Settanni CR, Pizzoferrato M, Schiavoni E, Turchini L, Amatucci V, Napolitano D, Bernabei T, Mora V, Laterza L, Papa A, Guidi L, Rapaccini GL, Gasbarrini A, Armuzzi A.

Abstract:

Link to Article

Oral Iron for IBD Patients: Lessons Learned at Time of COVID-19 Pandemic

D'Amico F, Peyrin-Biroulet L, Danese S.

Abstract:

Link to Article

Covid-19 and Exacerbation of Psoriasis

Ozaras R, Berk A, Ucar DH, Duman H, Kaya F, Mutlu H.

Abstract:

Link to Article

Response to: 'Hydroxychloroquine shortages during the COVID-19 pandemic' by Mendel et al

McInnes I.

Abstract:

Link to Article

Rheumatic diseases in intensive care unit patients with COVID-19

Moiseev S, Avdeev S, Brovko M, Yavorovskiy A, Novikov PI, Umbetova K, Akulkina L, Tsareva N, Fomin V.

Abstract:

Link to Article

Hydroxychloroquine shortages during the COVID-19 pandemic

Mendel A, Bernatsky S, Thorne JC, Lacaille D, Johnson SR, Vinet É.

Abstract:

Link to Article

Comorbidities and rheumatological diseases at the time of COVID-19. Response to: 'Rheumatic diseases in intensive care unit patients with COVID-19' by Moiseev et al

Monti S, Montecucco C.

Abstract:

Link to Article

Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander?

Ruscitti P, Berardicurti O, Barile A, Cipriani P, Shoenfeld Y, Iagnocco A, Giacomelli R.

Abstract:

Link to Article

Is Biologic Treatment of Hidradenitis Suppurativa During the COVID-19 Pandemic Different from Psoriasis Biologic Treatment?

Rosi E, Pimpinelli N, Prignano F.

Abstract:

Link to Article

Should coronavirus disease 2019 concern rheumatologists?

Kucharz EJ.

Abstract:

Link to Article

Starting a biologic therapy in IBD patients amidst COVID-19: hold, careful monitoring or testing?

Zingone F, Buda A, Savarino EV.

Abstract:

Link to Article

[Therapeutic options for the management of severe Covid-19: A rheumatology perspective]

Mendoza-Pinto C, García-Carrasco M, Realpozo PM, Méndez-Martínez S.

Abstract:

Link to Article

Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs

Michelena X, Borrell H, López-Corbeto M, López-Lasanta M, Moreno E, Pascual-Pastor M, Erra A, Serrat M, Espartal E, Antón S, Añez GA, Caparrós-Ruiz R, Pluma A, Trallero-Araguás E, Barceló-Bru M, Almirall M, De Agustín JJ, Segura JL, Julià A, Marsal S.

Abstract:

Link to Article

Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry

Brenner EJ, Ungaro RC, Gearry RB, Kaplan GG, Kissous-Hunt M, Lewis JD, Ng SC, Rahier JF, Reinisch W, Ruemmele FM, Steinwurz F, Underwood FE, Zhang X, Colombel JF, Kappelman MD.

Abstract:

Link to Article

Roles of Clinical Pharmacists in Caring for Patients with Inflammatory Bowel Disease during COVID-19

Bhat S, Farraye FA, Moss A.

Abstract:

Link to Article

The utility of fecal calprotectin in the era of COVID-19 pandemic

Abstract:

Link to Article

Opportunistic virus infections in psoriasis patients: the safer alternative of apremilast

Armesto S, González Vela C, González López MA.

Abstract:

Link to Article

Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?

Erre GL, Ferraccioli ES, Piga M, Mangoni A, Passiu G, Gremese E, Ferraccioli G.

Abstract:

Link to Article

Response to: 'Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?' by Erre et al

Graef ER, Liew JW, Kim AH, Sparks JA.

Abstract:

Link to Article

COVID-19 and Rheumatology patients on immunomodulatory therapy - can we extrapolate data from previous viral pandemics?

Jethwa H, Sullivan A, Abraham S.

Abstract:

Link to Article

Balancing risks and benefits in inflammatory bowel disease patients during the COVID-19 pandemic

Kotze PG, Peyrin-Biroulet L, Danese S.

Abstract:

Link to Article

Management Strategies of Autoimmune bullous diseases during the Outbreak of 2019 Novel Coronavirus Disease (COVID-19).

Chen P, Zhang G, Zhan Y.

Abstract:

Link to Article

Evans syndrome in a patient with COVID-19.

Li M, Nguyen CB, Yeung Z, Sanchez K, Rosen D, Bushan S.

Abstract:

Link to Article

[COVID-19 and inflammatory bowel disease: questions arising from patient care and follow-up during the initial phase of the pandemic (February-April 2020)]

Marín-Jiménez I, Zabana Y, Rodríguez-Lago I, Marín L, Acosta MB, Esteve M; en representación de GETEII y GETECCU.

Abstract:

Link to Article

Implementing Telemedicine in Inflammatory Bowel Disease: is COVID-19 the definitive trigger?

Hoyo JD, Aguas M.

Abstract:

Link to Article

Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients

Fortuné C, Gietzen A, Guillot G, Lewis N, Nielsen K, Richard M, Sauvé M, Welling J; SPIN Investigators, Baron M, Furst DE, Gottesman K, Malcarne V, Mayes MD, Mouthon L, Nielson WR, Riggs R, Wigley F, Assassi S, Boutron I, Ells C, van den Ende C, Fligelstone K, Frech T, Godard D, Harel D, Hinchcliff M, Hudson M, Johnson SR, Larche M, Leite C, Nguyen C, Pope J, Portales A, Rannou F, Reyna TSR, Schouffoer AA, Suarez-Almazor ME, Agard C, Albert A, André M, Arsenault G, Benzidia I, Bernstein EJ, B

Abstract:

Link to Article

The risk of respiratory tract infections and symptoms in psoriasis patients treated with IL-17-pathway inhibiting biologics: A meta-estimate of pivotal trials relevant to decision-making during the COVID-19 pandemic

Wan MT, Shin DB, Winthrop KL, Gelfand JM.

Abstract:

Link to Article

COVID-19 knowledge prevents biologics discontinuation: data from an Italian multi-center survey during RED-ZONE declaration.

Bragazzi NL, Riccò M, Pacifico A, Malagoli P; COVID19 Dermatological Task Force, Young Dermatologists Italian Network., Kridin K, Pigatto P, Damiani G.

Abstract:

Link to Article

Disability and quality of life before and during the COVID-19 outbreak: A cross-sectional study in inflammatory bowel disease patients

Azzam NA, Aljebreen A, Almuhareb A, Almadi MA.

Abstract:

Link to Article

Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: 'COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs' by Conticini et al.

Monti S, Montecucco C.

Abstract:

Link to Article

COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs.

Conticini E, Bargagli E, Bardelli M, Rana GD, Baldi C, Cameli P, Gentileschi S, Bennett D, Falsetti P, Lanzarone N, Bellisai F, Barreca C, D'Alessandro R, Cantarini L, Frediani B.

Abstract:

Link to Article

Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids.

Abstract:

Link to Article

Health status of patients with Autoimmune Liver Disease during SARS-CoV-2 outbreak in northern Italy.

Abstract:

Link to Article

Patterns of care for inflammatory bowel disease in China during the COVID-19 pandemic.

Abstract:

Link to Article

Views of patients with inflammatory bowel disease on the COVID-19 pandemic: a global survey.

Abstract:

Link to Article

COVID-19 with rheumatic diseases: a report of 5 cases.

Cheng C, Li C, Zhao T, Yue J, Yang F, Yan Y, Liu X.

Abstract:

Link to Article

COVID-19 and your rheumatology patients.

Calabrese C.

Abstract:

Link to Article

Excessive anxiety in IBD patients is unnecessary for COVID-19.

Abstract:

Link to Article

Keeping on the high quality of healthcare in Greek Inflammatory Bowel Disease patients in the SARS-CoV-2 era.

Abstract:

Link to Article

Could Patients With Inflammatory Bowel Disease Treated with Immunomodulators or Biologics Be at Lower Risk for Severe Forms of Covid-19?

Abstract:

Link to Article

Impact of COVID-19 outbreak on the management of patients with severe IBD: a domino effect.

Abstract:

Link to Article

Association of outdoor activity restriction and income loss with patient-reported outcomes of psoriasis during the COVID-19 pandemic: A web-based survey.

Abstract:

Link to Article

Experience of a second-level Rheumatology Clinic during the Covid-19 quarantine.

Colaci M, Aprile ML, Sambataro D, Sambataro G, Malatino L.

Abstract:

Link to Article

A survey of psoriasis patients on biologics during COVID-19: a single centre experience.

Burlando M, Carmisciano L, Cozzani E, Parodi A.

Abstract:

Link to Article

Tocilizumab: From the Rheumatology Practice to the Fight Against COVID-19, a virus infection with multiple faces.

González-Gay MA, Mayo J, Castañeda S, Cifrián JM, Hernández-Rodríguez J.

Abstract:

Link to Article

Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic.

Benson-Pope SJ, Gearry RB.

Abstract:

Link to Article

Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic-authors' reply.

King DS, Trudgill NJ, Adderley NJ.

Abstract:

Link to Article

COVID-19 with rheumatic diseases: a report of 5 cases.

Cheng C, Li C, Zhao T, Yue J, Yang F, Yan Y, Liu X.

Abstract:

Link to Article

Response to: 'Patients with lupus are not protected from COVID-19: a comment' by Sawalha, 'No evidence so far on the protective effect of hydroxycloroquin to prevent COVID-19: response to the Comment by Joob and Wiwanitkit' by Rom√£o et al and 'SLE patients are not immune to COVID-19: importance of s...

Joob B, Wiwanitkit V.

Abstract:

Link to Article

How to Effectively Support Patients with Rheumatic Conditions Now and Beyond COVID-19.

Décary S, Barton JL, Proulx L, Richards DP, Paterson G, de Wit M, Toupin-April K.

Abstract:

Link to Article

COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.

Bozzalla Cassione E, Zanframundo G, Biglia A, Codullo V, Montecucco C, Cavagna L.

Abstract:

Link to Article

Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature.

Rosen MH, Axelrad J, Hudesman D, Rubin DT, Chang S.

Abstract:

Link to Article

Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical Trials.

Balevic SJ, Hornik CP, Green TP, Clowse MEB, Gonzalez D, Maharaj AR, Schanberg LE, Eudy AM, Swamy GK, Hughes BL, Cohen-Wolkowiez M.

Abstract:

Link to Article

Keeping lupus patients on hydroxychloroquine during the COVID-19 pandemic.

Littlejohn E.

Abstract:

Link to Article

COVID-19 in Patients with Myasthenia Gravis.

Anand P, Slama MCC, Kaku M, Ong C, Cervantes-Arslanian AM, Zhou L, David WS, Guidon AC.

Abstract:

Link to Article

Inflammatory bowel disease and the SARS-CoV-2 pandemic: more speed, less haste.

Abstract:

Link to Article

COVID-19 and biologics for psoriasis: a high-epidemic area experience - Bergamo, Lombardy, Italy.

Abstract:

Link to Article

SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California.

Abstract:

Link to Article

Capturing patient-reported outcomes during the COVID-19 pandemic: Development of the COVID-19 Global Rheumatology Alliance Patient Experience Survey.

Sirotich E, Dillingham S, Grainger R, Hausmann JS; COVID-19 Global Rheumatology Alliance Steering Committee..

Abstract:

Link to Article

Inflammatory Bowel Diseases and Biological Treatment in SARS-CoV-2 Era. Why Not?

Grassia R, Soro S, Conti CB.

Abstract:

Link to Article

COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management.

Mugheddu C, Pizzatti L, Sanna S, Atzori L, Rongioletti F.

Abstract:

Link to Article

Anti-TNF-α Agents in Inflammatory Bowel Disease and Course of COVID-19.

Tursi A, Vetrone LM, Papa A.

Abstract:

Link to Article

Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.

Konig MF, Kim AH, Scheetz MH, Graef ER, Liew JW, Simard J, Machado PM, Gianfrancesco M, Yazdany J, Langguth D, Robinson PC; COVID-19 Global Rheumatology Alliance..

Abstract:

Link to Article

Challenges in chronic paediatric disease during the COVID-19 pandemic: diagnosis and management of inflammatory bowel disease in children.

Ashton JJ, Batra A, Coelho TAF, Afzal NA, Beattie RM.

Abstract:

Link to Article

Response to "Lupus anticoagulant is frequent in patients with Covid-19".

Tang N.

Abstract:

Link to Article

Improvement of SARS-CoV2 symptoms following Guselkumab injection in a psoriatic patient.

Benhadou F, Del Marmol V.

Abstract:

Link to Article

Coagulopathy of COVID-19 and antiphospholipid antibodies.

Connell NT, Battinelli EM, Connors JM.

Abstract:

Link to Article

Evolution of COVID-19 infection in 4 psoriatic patients treated with biological drugs.

Conti A, Lasagni C, Bigi L, Pellacani G.

Abstract:

Link to Article

Widening Disparities Among Patients with Rheumatic Diseases in the COVID-19 Era: An Urgent Call to Action.

Feldman CH, Ramsey-Goldman R.

Abstract:

Link to Article

Initial data from the COVID-19 Global Rheumatology Alliance provider registries - Authors' reply.

Abstract:

Link to Article

Initial data from the COVID-19 Global Rheumatology Alliance provider registries.

Abstract:

Link to Article

The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients.

Abstract:

Link to Article

Author Correction: Management of IBD during the COVID-19 outbreak: resetting clinical priorities.

Danese S, Cecconi M, Spinelli A.

Abstract:

Link to Article

Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series.

Aouba A, Baldolli A, Geffray L, Verdon R, Bergot E, Martin-Silva N, Justet A.

Abstract:

Link to Article

Autoimmune hemolytic anemia associated with Covid-19 infection.

Lazarian G, Quinquenel A, Bellal M, Siavellis J, Jacquy C, Re D, Merabet F, Mekinian A, Braun T, Damaj G, Delmer A, Cymbalista F.

Abstract:

Link to Article

COVID-19: an unexpected indication for anti-rheumatic therapies?

Lucchino B, Di Franco M, Conti F.

Abstract:

Link to Article

The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance.

Wallace ZS, Bhana S, Hausmann JS, Robinson PC, Sufka P, Sirotich E, Yazdany J, Grainger R.

Abstract:

Link to Article

Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2 - exploring RAS inhibitors.

Garg M, Royce SG, Lubel JS.

Abstract:

Link to Article

Practical Advice for Management of IBD Patients during the COVID-19 Pandemic: A World Endoscopy Organization Statement.

Neumann H, Emura F, Bokemeyer B, Guda N, Tajiri H, Matsumoto T, Rubin DT.

Abstract:

Link to Article

Simultaneous Onset of COVID-19 and Autoimmune Hemolytic Anemia.

Lopez C, Kim J, Pandey A, Huang T, DeLoughery TG.

Abstract:

Link to Article

Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.

Bowles L, Platton S, Yartey N, Dave M, Lee K, Hart DP, MacDonald V, Green L, Sivapalaratnam S, Pasi KJ, MacCallum P.

Abstract:

Link to Article

Excitement around hydroxychloroquine for treating COVID-19 causes challenges for rheumatology.

Abstract:

Link to Article

Global rheumatology in the time of COVID-19.

Abstract:

Link to Article

Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19?

Kutlu Ö, Metin A.

Abstract:

Link to Article

Response to 'To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic' by Parperis.

Spinelli FR, Ceccarelli F, Di Franco M, Conti F.

Abstract:

Link to Article

A challenging case of psoriasis flare-up after COVID-19 infection.

Abstract:

Link to Article

Going Viral: Management of IBD in the Era of the COVID-19 Pandemic.

Gutin LS, Lam AY, Velayos FS, Santos SA.

Abstract:

Link to Article

Screening for active COVID-19 infection and immunization status prior to biologic therapy in IBD patients at the time of the pandemic outbreak.

Abstract:

Link to Article

2019 Novel Coronavirus Disease (COVID-19) in patients with Inflammatory Bowel Diseases.

Taxonera C, Sagastagoitia I, Alba C, Mañas N, Olivares D, Rey E.

Abstract:

Link to Article

Comment on "Antipsoriatic treatments during COVID-19 outbreak".

Abdelmaksoud A, Goldust M, Vestita M.

Abstract:

Link to Article

Biologic therapy for psoriasis during the COVID-19 outbreak: the choice is to weigh risks and benefits.

Conforti C, Giuffrida R, Dianzani C, Di Meo N, Zalaudek I.

Abstract:

Link to Article

SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor.

Balestri R, Rech G, Girardelli CR.

Abstract:

Link to Article

Identifying rheumatic disease patients at high risk and requiring shielding during the COVID-19 pandemic.

Price E, MacPhie E, Kay L, Lanyon P, Griffiths B, Holroyd C, Abhishek A, Youngstein T, Bailey K, Clinch J, Shaikh M, Rivett A.

Abstract:

Link to Article

Biologics increase the risk of SARS- CoV-2 infection and hospitalization, but not ICU admission and death: real-life data from a large cohort during RED-ZONE declaration.

Damiani G, Pacifico A, Bragazzi NL, Malagoli P.

Abstract:

Link to Article

What Does the COVID-19 Pandemic Mean for Rheumatology Patients?

Pope JE.

Abstract:

Link to Article

Combating physical inactivity during the COVID-19 pandemic.

Pinto AJ, Dunstan DW, Owen N, Bonf√° E, Gualano B.

Abstract:

Link to Article

Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study.

Bezzio C, Saibeni S, Variola A, Allocca M, Massari A, Gerardi V, Casini V, Ricci C, Zingone F, Amato A, Caprioli F, Lenti MV, Viganò C, Ascolani M, Bossa F, Castiglione F, Cortelezzi C, Grossi L, Milla M, Morganti D, Pastorelli L, Ribaldone DG, et al.

Abstract:

Link to Article

Non-steroidal anti-inflammatory treatment during covid-19: friend or foe? Response to: 'Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)' by Giollo et al.

Monti S, Montecucco C.

Abstract:

Link to Article

Diagnostic and therapeutic challenges for patients with ANCA-associated vasculitides at the time of COVID-19. Response to: 'Rituximab for granulomatosis with polyangiitis in the pandemic of COVID-19: lessons from a case with severe pneumonia' by Guilpain et al.

Monti S, Montecucco C.

Abstract:

Link to Article

Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept.

Duret PM, Sebbag E, Mallick A, Gravier S, Spielmann L, Messer L.

Abstract:

Link to Article

Letter: Gastrointestinal ACE2, COVID-19 and IBD - opportunity in the face of tragedy?

Abstract:

Link to Article

Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States.

Aggarwal S, Garcia-Telles N, Aggarwal G, Lavie C, Lippi G, Henry BM.

Abstract:

Link to Article

The impact of COVID-19 on rheumatology clinical practice and university teaching in Sydney, Australia.

Abstract:

Link to Article

Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management.

Matucci-Cerinic M, Bruni C, Allanore Y, Clementi M, Dagna L, Damjanov NS, de Paulis A, Denton CP, Distler O, Fox D, Furst DE, Khanna D, Krieg T, Kuwana M, Lee EB, Li M, Pillai S, Wang Y, Zeng X, Taliani G.

Abstract:

Link to Article

American College of Rheumatology Guidance for the Management of Adult Patients with Rheumatic Disease During the COVID-19 Pandemic.

Mikuls TR, Johnson SR, Fraenkel L, Arasaratnam RJ, Baden LR, Bermas BL, Chatham W, Cohen S, Costenbader K, Gravallese EM, Kalil AC, Weinblatt ME, Winthrop K, Mudano AS, Turner A, Saag KG.

Abstract:

Link to Article

Ambulatory Management of perianal Crohn's Disease during the Covid-19 Pandemic.

Andrea D, Bruno S, Giuseppe S.

Abstract:

Link to Article

Review Article: Prevention, Diagnosis and Management of COVID-19 in the Inflammatory Bowel Disease Patient.

Al-Ani A, Prentice R, Rentsch C, Johnson D, Ardalan Z, Heerasing N, Garg M, Campbell S, Sasadeusz J, Macrae F, Ng SC, Rubin DT, Christensen B.

Abstract:

Link to Article

Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic.

Mahil SK, Yiu ZZN, Mason KJ, Dand N, Coker B, Wall D, Fletcher G, Bosma A, Capon F, Iversen L, Langan SM, Di Meglio P, Musters A, Prieto-Merino D, Tsakok T, Warren RB, Flohr C, Spuls P, Griffiths CEM, Barker J, Irvine AD, Smith CH; et al.

Abstract:

Link to Article

[Rheumatology and COVID-19].

Dumusc A, Dan D.

Abstract:

Link to Article

[Autoimmune diseases in the context of pandemic COVID-19].

Horisberger A, Moi L, Ribi C, Comte D.

Abstract:

Link to Article

Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/Covid-19 pandemic.

Schulze-Koops H, Specker C, Iking-Konert C, Holle J, Moosig F, Krueger K.

Abstract:

Link to Article

Response to 'Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?' by Moiseev et al.

Spinelli FR, Ceccarelli F, Di Franco M, Conti F.

Abstract:

Link to Article

Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey.

Tomelleri A, Sartorelli S, Campochiaro C, Baldissera EM, Dagna L.

Abstract:

Link to Article

Anti-inflammatory therapy may ameliorate the clinical picture of COVID-19.

Moutsopoulos HM.

Abstract:

Link to Article

The impact of COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biologic therapy: the Northern Italy experience.

Gisondi P, Facheris P, Dapavo P, Piaserico S, Conti A, Naldi L, Cazzaniga S, Malagoli P, Costanzo A.

Abstract:

Link to Article

[Current guidance of the German Society of Rheumatology for the care of patients with rheumatic diseases during the SARS-CoV-2/Covid 19 pandemic].

Schulze-Koops H, Holle J, Moosig F, Specker C, Aries P, Burmester G, Fiehn C, Hoyer B, Krause A, Leipe J, Lorenz HM, Schneider M, Sewerin P, Voormann A, Wager U, Krüger K, Iking-Konert C; im Auftrag der Kommission Pharmakotherapie und des Vorstandes der Deutschen Gesellschaft für Rheumatologie..

Abstract:

Link to Article

Case Report of a SARS-CoV-2 Infection in a Patient With Ulcerative Colitis on Tofacitinib.

Jacobs J, Clark-Snustad K, Lee S.

Abstract:

Link to Article

Managing patients with rheumatic conditions during the covid-19 pandemic.

Caporali R, Favalli EG.

Abstract:

Link to Article

Online management of rheumatoid arthritis during COVID-19 pandemic.

Zhang Y, Wang J, Zhao L, Xiao J, Shi Z.

Abstract:

Link to Article

The conundrum of COVID-19 treatment targets: the close correlation with rheumatology. Response to: 'Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology pracitioners from India' by Gupta et al and 'Antirheumatic agents in covid-19: is IL-6 the right target?...

Monti S, Montecucco C.

Abstract:

Link to Article

Biologics for psoriasis in COVID-19 era: what do we know?

Megna M, Napolitano M, Patruno C, Fabbrocini G.

Abstract:

Link to Article

Rheumotologitsts' View on the Use of Hydroxychloroquine to Treat COVID-19.

Sun X, Ni Y, Zhang M.

Abstract:

Link to Article

The Question of Whether to Remain on Therapy for Chronic Rheumatic Diseases in the Setting of the Covid-19 Pandemic.

Cron RQ, Chatham WW.

Abstract:

Link to Article

Incidence and clinical course of COVID-19 in patients with connective tissue diseases: a descriptive observational analysis.

Favalli EG, Agape E, Caporali R.

Abstract:

Link to Article

Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs.

Filocamo G, Minoia F, Carbogno S, Costi S, Romano M, Cimaz R; Pediatric Rheumatology Group of the Milan Area..

Abstract:

Link to Article

Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic.

Kasperkiewicz M, Schmidt E, Fairley JA, Joly P, Payne AS, Yale ML, Zillikens D, Woodley DT.

Abstract:

Link to Article

Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD.

Burgueño JF, Reich A, Hazime H, Quintero MA, Irina F, Fritsch J, Santander AM, Brito N, Damas OM, Deshpande A, Kerman DH, Zhang L, Gao Z, Ban Y, Wang L, Pignac-Kobinger J, Abreu MT.

Abstract:

Link to Article

Patients with lupus are not protected from COVID-19.

Sawalha AH.

Abstract:

Link to Article

Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.

Mathian A, Mahevas M, Rohmer J, Roumier M, Cohen-Aubart F, Amador-Borrero B, Barrelet A, Chauvet C, Chazal T, Delahousse M, Devaux M, Euvrard R, Fadlallah J, Florens N, Haroche J, Hié M, Juillard L, Lhote R, Maillet T, Richard-Colmant G, Palluy JB, Pha M, et al.

Abstract:

Link to Article

Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biological treatment and renal transplanted recipients in maintenance immunosuppressive treatment.

Gisondi P, Zaza G, Del Giglio M, Rossi M, Iacono V, Girolomoni G.

Abstract:

Link to Article

Characteristics and prognosis of patients with inflammatory bowel disease during the SARS-CoV-2 pandemic in the Basque Country (Spain).

Rodríguez-Lago I, Ramírez de la Piscina P, Elorza A, Merino O, Ortiz de Zárate J, Cabriada JL.

Abstract:

Link to Article

COVID-19, osteoarthritis and women's health.

Mobasheri A.

Abstract:

Link to Article

Translating IL-6 biology into effective treatments.

Choy EH, De Benedetti F, Takeuchi T, Hashizume M, John MR, Kishimoto T.

Abstract:

Link to Article

Management of inflammatory bowel disease during COVID-19 pandemic.

Ribaldone DG, Astegiano M, Actis GC, Pellicano R.

Abstract:

Link to Article

Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: 'Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and 'SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment' by Joob and Wiwanitkit.

Monti S, Montecucco C.

Abstract:

Link to Article

Myositis as a manifestation of SARS-CoV-2.

Beydon M, Chevalier K, Al Tabaa O, Hamroun S, Delettre AS, Thomas M, Herrou J, Riviere E, Mariette X.

Abstract:

Link to Article

SLE patients are not immune to covid-19: importance of sending the right message across.

Goyal M.

Abstract:

Link to Article

Lupus anticoagulant is frequent in patients with Covid-19.

Harzallah I, Debliquis A, Drénou B.

Abstract:

Link to Article

What is the true incidence of COVID-19 in patients with rheumatic diseases?

Favalli EG, Ingegnoli F, Cimaz R, Caporali R.

Abstract:

Link to Article

To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic.

Parperis K.

Abstract:

Link to Article

Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID).

Giollo A, Adami G, Gatti D, Idolazzi L, Rossini M.

Abstract:

Link to Article

Implications of COVID-19 for the management of patients with inflammatory rheumatic diseases.

Richez C, Lazaro E, Lemoine M, Truchetet ME, Schaeverbeke T.

Abstract:

Link to Article

COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country.

Licciardi F, Giani T, Baldini L, Favalli EG, Caporali R, Cimaz R.

Abstract:

Link to Article

Management of inflammatory bowel disease patients in the COVID-19 pandemic era: a Brazilian tertiary referral center guidance.

Queiroz NSF, Barros LL, Azevedo MFC, Oba J, Sobrado CW, Carlos AS, Milani LR, Sipahi AM, Dami√£o AOMC.

Abstract:

Link to Article

Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?

Xie W, Wang Y, Zhang Z.

Abstract:

Link to Article

Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?

Moiseev S, Avdeev S, Brovko M, Novikov P, Fomin V.

Abstract:

Link to Article

The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19.

Perricone C, Triggianese P, Bartoloni E, Cafaro G, Bonifacio AF, Bursi R, Perricone R, Gerli R.

Abstract:

Link to Article

Clinical and Autoimmune Characteristics of Severe and Critical Cases with COVID-19.

Zhou Y, Han T, Chen J, Hou C, Hua L, He S, Guo Y, Zhang S, Wang Y, Yuan J, Zhao C, Zhang J, Jia Q, Zuo X, Li J, Wang L, Cao Q, Jia E.

Abstract:

Link to Article

Challenges in the Care of IBD Patients During the CoViD-19 Pandemic: Report From a "Red Zone" Area in Northern Italy.

Occhipinti V, Pastorelli L.

Abstract:

Link to Article

COVID-19 and psoriasis : should we fear for patients treated with biologics?

Amerio P, Prignano F, Giuliani F, Gualdi G.

Abstract:

Link to Article

Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs.

Song J, Kang S, Choi SW, Seo KW, Lee S, So MW, Lim DH.

Abstract:

Link to Article

Faecal calprotectin indicates intestinal inflammation in COVID-19.

Effenberger M, Grabherr F, Mayr L, Schwaerzler J, Nairz M, Seifert M, Hilbe R, Seiwald S, Scholl-Buergi S, Fritsche G, Bellmann-Weiler R, Weiss G, Müller T, Adolph TE, Tilg H.

Abstract:

Link to Article

Covid-19 infection in Crohn's disease under treatment with adalimumab.

Tursi A, Angarano G, Monno L, Saracino A, Signorile F, Ricciardi A, Papa A.

Abstract:

Link to Article

Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia.

Guilpain P, Le Bihan C, Foulongne V, Taourel P, Pansu N, Maria ATJ, Jung B, Larcher R, Klouche K, Le Moing V.

Abstract:

Link to Article

Experiences of Patients with Rheumatic Diseases in the US During Early Days of the COVID-19 Pandemic.

Michaud K, Wipfler K, Shaw Y, Simon TA, Cornish A, England BR, Ogdie A, Katz P.

Abstract:

Link to Article

Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China.

An P, Ji M, Ren H, Su J, Ding NS, Kang J, Yin A, Zhou Q, Shen L, Zhao L, Jiang X, Xiao Y, Tan W, Lv X, Li J, Liu S, Zhou J, Chen H, Xu Y, Liu J, Chen M, Cao J, et al.

Abstract:

Link to Article

Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries.

Gianfrancesco MA, Hyrich KL, Gossec L, Strangfeld A, Carmona L, Mateus EF, Sufka P, Grainger R, Wallace Z, Bhana S, Sirotich E, Liew J, Hausmann JS, Costello W, Robinson P, Machado PM, Yazdany J; COVID-19 Global Rheumatology Alliance Steering Committee..

Abstract:

Link to Article

Unity amidst uncertainty: COVID-19 pandemic fosters collaboration in rheumatology community.

The Lancet Rheumatology.

Abstract:

Link to Article

Successful Guselkumab treatment in a psoriatic patient affected with Cornelia de Lange Syndrome, and prosecution during the COVID-19 pandemic.

Mugheddu C, Dell'Antonia M, Sanna S, Agosta D, Atzori L, Rongioletti F.

Abstract:

Link to Article

Inflammatory bowel diseases and COVID-19: the invisible enemy.

D'Amico F, Peyrin-Biroulet L, Danese S.

Abstract:

Link to Article

Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period.

Iacucci M, Cannatelli R, Labarile N, Mao R, Panaccione R, Danese S, Kochhar GS, Ghosh S, Shen B.

Abstract:

Link to Article

Maintaining the quality standards of care for inflammatory bowel disease patients during the COVID-19 pandemic.

Allocca M, Fiorino G, Furfaro F, Gilardi D, Radice S, D'Amico F, Zilli A, Danese S.

Abstract:

Link to Article

[A cross sectional study on patients with inflammatory rheumatic diseases in terms of their compliance to their immunsuppressive medication during COVID-19 pandemic].

Schmeiser T, Broll M, Dormann A, Fräbel C, Hermann W, Hudowenz O, Keil F, Müller-Ladner U, Özden F, Pfeiffer U, Saech J, Schwarting A, Stapfer G, Steinchen N, Storck-Müller K, Strunk J, Thiele A, Triantafyllias K, Wassenberg S, Wilden E, Hasseli R.

Abstract:

Link to Article

Impact of anti-tnfα antibodies on the risk of Covid-19 and its severity in patients with inflammatory Bowel Diseases.

Tursi A, Papa A.

Abstract:

Link to Article

Will COVID-19 infection be less severe in ulcerative colitis than in Crohn's patients due to a lower rate of smokers?

Peyrin-Biroulet C, D'Amico F, Peyrin-Biroulet L.

Abstract:

Link to Article

Covid-19 and immunomodulation in IBD.

Neurath MF.

Abstract:

Link to Article

British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic.

Kennedy NA, Jones GR, Lamb CA, Appleby R, Arnott I, Beattie RM, Bloom S, Brooks AJ, Cooney R, Dart RJ, Edwards C, Fraser A, Gaya DR, Ghosh S, Greveson K, Hansen R, Hart A, Hawthorne AB, Hayee B, Limdi JK, Murray CD, Parkes GC, et al.

Abstract:

Link to Article

Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19.

Li G, He X, Zhang L, Ran Q, Wang J, Xiong A, Wu D, Chen F, Sun J, Chang C.

Abstract:

Link to Article

Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?

Di Altobrando A, Patrizi A, Bardazzi F.

Abstract:

Link to Article

Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears.

Megna M, Ruggiero A, Marasca C, Fabbrocini G.

Abstract:

Link to Article

Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times.

Brownstone ND, Thibodeaux QG, Reddy VD, Myers BA, Chan SY, Bhutani T, Liao W.

Abstract:

Link to Article

COVID-19 and rheumatology: first steps towards a different future?

McInnes IB.

Abstract:

Link to Article

Antirheumatic agents in covid-19: is IL-6 the right target?

Capecchi PL, Lazzerini PE, Volterrani L, Mazzei MA, Rossetti B, Zanelli G, Bennett D, Bargagli E, Franchi F, Cameli M, Valente S, Cantarini L, Frediani B.

Abstract:

Link to Article

Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India.

Gupta L, Misra DP, Agarwal V, Balan S, Agarwal V.

Abstract:

Link to Article

COVID-19, immune system response, hyperinflammation and repurposing anti-rheumatic drugs.

Tufan A, Avanoğlu Güler A, Matucci-Cerinic M.

Abstract:

Link to Article

Dealing with COVID-19 in a Pediatric Rheumatology Unit in Italy.

Costi S, Caporali R, Cimaz R.

Abstract:

Link to Article

Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times.

Brownstone ND, Thibodeaux QG, Reddy VD, Myers BA, Chan SY, Bhutani T, Liao W.

Abstract:

Link to Article

Role of immunosuppressive therapy in rheumatic diseases concurrent with covid-19.

Lu C, Li S, Liu Y.

Abstract:

Link to Article

Does hydroxychloroquine prevent the transmission of covid-19?

Heldwein FL, Calado A.

Abstract:

Link to Article

SLE, hydroxychloroquine and no SLE patients with covid-19: a comment.

Joob B, Wiwanitkit V.

Abstract:

Link to Article

Festina lente: hydroxychloroquine, covid-19 and the role of the rheumatologist.

Graef ER, Liew JW, Putman MS, Simard JF, Sirotich E, Berenbaum F, Duarte-García A, Grainger R, Harrison C, Konig MF, Korsten P, Proulx L, Richards DP, Robinson PC, Sattui SE, Ugarte-Gil MF, Young KJ, Kim AH, Sparks JA; COVID-19 Global Rheumatology Alliance..

Abstract:

Link to Article

Immune Thrombocytopenic Purpura in a Patient with Covid-19.

Zulfiqar AA, Lorenzo-Villalba N, Hassler P, Andrès E.

Abstract:

Link to Article

Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in sardinia (Italy).

Atzori L, Mugheddu C, Addis G, Sanna S, Satta R, Ferreli C, Atzori MG, Montesu MA, Rongioletti F.

Abstract:

Link to Article

SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor.

Messina F, Piaserico S.

Abstract:

Link to Article

Concerns related to COVID-19 pandemic among patients with Inflammatory Bowel Disease, and its influence on patients management.

Bodini G, Demarzo MG, Casagrande E, De Maria C, Kayali S, Ziola S, Giannini EG.

Abstract:

Link to Article

Pathogenic Priming Likely Contributes to Serious and Critical Illness and Mortality in COVID-19 via Autoimmunity.

Lyons-Weiler J.

Abstract:

Link to Article

Psoriasis and Psoriatic Arthritis: how to manage Immunosuppressants in COVID-19‚Äâdays.

Coletto LA, Favalli EG, Caporali R.

Abstract:

Link to Article

Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?

Liu B, Li M, Zhou Z, Guan X, Xiang Y.

Abstract:

Link to Article

COVID-19 - Considerations for the paediatric rheumatologist.

Hedrich CM.

Abstract:

Link to Article

Reply to: "Biologics for psoriasis during COVID-19 outbreak".

Abstract:

Link to Article

Biologics for psoriasis during COVID-19 outbreak.

Di Lernia V.

Abstract:

Link to Article

COVID-19, syphilis and biologic therapies for psoriasis and psoriatic arthritis: A word of caution

.

Abstract:

Link to Article

Adalimumab for Treatment of Hidradenitis Suppurativa During the COVID-19 Pandemic: Safety Considerations.

Blaszczak A, Trinidad JCL, Cartron AM.

Abstract:

Link to Article

AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary.

Rubin DT, Feuerstein JD, Wang AY, Cohen RD.

Abstract:

Link to Article

Rapid and Severe Covid-19 Pneumonia with Severe Acute Chest Syndrome in a Sickle Cell Patient Successfully Treated with Tocilizumab.

De Luna G, Habibi A, Deux JF, Colard M, d'Alexandry d'Orengiani ALPH, Schlemmer F, Joher N, Kassasseya C, Pawlotsky JM, Ourghanlian C, Michel M, Mekontso-Dessap A, Bartolucci P.

Abstract:

Link to Article

Telemedicine for Pediatric Inflammatory bowel disease in the Era of COVID-19.

Verstraete SG, Sola AM, Ali SA.

Abstract:

Link to Article

A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in Coronavirus Disease-19 (COVID-19).

Shah S, Das S, Jain A, Misra DP, Negi VS.

Abstract:

Link to Article

Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets.

Misra DP, Agarwal V, Gasparyan AY, Zimba O.

Abstract:

Link to Article

Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic.

Torres T, Puig L.

Abstract:

Link to Article

Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients.

Sawalha AH, Zhao M, Coit P, Lu Q.

Abstract:

Link to Article

Stand Together and Deliver: Challenges and Opportunities for Rheumatology Education During the COVID-19 Pandemic.

Abstract:

Link to Article

Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus.

Jakhar D, Kaur I.

Abstract:

Link to Article

Possible Consequences of a Shortage of Hydroxychloroquine for Lupus Patients Amid the COVID-19 Pandemic.

Peschken CA.

Abstract:

Link to Article

Learning from Adversity: Lessons from the COVID-19 Crisis.

Putman MS, Ruderman EM.

Abstract:

Link to Article

Corona (COVID-19) time musings: Our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning.

Shoenfeld Y.

Abstract:

Link to Article

SECURE-Psoriasis: a de-identified registry of psoriasis patients diagnosed with COVID-19.

Balogh EA, Heron C, Feldman SR, Huang WW.

Abstract:

Link to Article

Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon

Haşlak F, Yıldız M, Adrovic A, Barut K, Kasapçopur Ö.

Abstract:

Link to Article

A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic?

Kutlu Ö, Metin A.

Abstract:

Link to Article

Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy.

Ceribelli A, Motta F, De Santis M, Ansari AA, Ridgway WM, Gershwin ME, Selmi C.

Abstract:

Link to Article

ACE2 at the centre of COVID-19 from paucisymptomatic infections to severe pneumonia.

Rivellese F, Prediletto E.

Abstract:

Link to Article

The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease.

McGonagle D, Sharif K, O'Regan A, Bridgewood C.

Abstract:

Link to Article

What is the role of rheumatologists in the era of COVID-19?

Marotto D, Sarzi-Puttini P.

Abstract:

Link to Article

Biologic therapy for psoriasis during the covid-19 outbreak is not a choice.

Bardazzi F, Loi C, Sacchelli L, Di Altobrando A.

Abstract:

Link to Article

Uneventful course in IBD patients during SARS-CoV-2 outbreak in northern Italy.

Norsa L, Indriolo A, Sansotta N, Cosimo P, Greco S, D'Antiga L.

Abstract:

Link to Article

COVID-19, syphilis and biologic therapies for psoriasis and psoriatic arthritis: A word of caution.

Kansal NK.

Abstract:

Link to Article

Management of Inflammatory Bowel Diseases in the Wake of COVID-19 Pandemic.

Pasha SB, Fatima H, Ghouri YA.

Abstract:

Link to Article

COVID-19 in children and altered inflammatory responses.

Molloy EJ, Bearer CF.

Abstract:

Link to Article

Immunosuppression drug-related and clinical manifestation of Coronavirus disease 2019: A therapeutical hypothesis.

Romanelli A, Mascolo S.

Abstract:

Link to Article

COVID-19 in post-transplantation patients- report of two cases.

Huang J, Lin H, Wu Y, Fang Y, Kumar R, Chen G, Lin S.

Abstract:

Link to Article

A familial cluster, including a kidney transplant recipient, of Coronavirus Disease 2019 (COVID-19) in Wuhan, China.

Chen S, Yin Q, Shi H, Du D, Chang S, Ni L, Qiu H, Chen Z, Zhang J, Zhang W.

Abstract:

Link to Article

The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic.

Robinson PC, Yazdany J.

Abstract:

Link to Article

Hydroxychloroquine: a potential ethical dilemma for rheumatologists during the COVID-19 pandemic.

Scuccimarri R, Sutton E, Fitzcharles MA.

Abstract:

Link to Article

Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.

Monti S, Balduzzi S, Delvino P, Bellis E, Quadrelli VS, Montecucco C.

Abstract:

Link to Article

COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD.

Mihai C, Dobrota R, Schröder M, Garaiman A, Jordan S, Becker MO, Maurer B, Distler O.

Abstract:

Link to Article

To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic.

Spinelli FR, Ceccarelli F, Di Franco M, Conti F.

Abstract:

Link to Article

Comment on "COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action".

.

Abstract:

Link to Article

The COVID-19 outbreak and rheumatologic skin diseases.

Arora G, Kassir M, Jafferany M, Galadari H, Lotti T, Satolli F, Sadoughifar R, Sitkowska Z, Goldust M.

Abstract:

Link to Article

COVID-19 and Paediatric Inflammatory Bowel Diseases: Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto group of ESPGHAN.

Turner D, Huang Y, Martín-de-Carpi J, Aloi M, Focht G, Kang B, Zhou Y, Sanchez C, Kappelman MD, Uhlig HH, Pujol-Muncunill G, Ledder O, Lionetti P, Dias JA, Ruemmele FM, Russell RK; Paediatric IBD Porto group of ESPGHAN..

Abstract:

Link to Article

The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality.

Zhang C, Wu Z, Li JW, Zhao H, Wang GQ.

Abstract:

Link to Article

Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs.

Georgiev T.

Abstract:

Link to Article

COVID-19, rheumatic diseases and immunosuppressive drugs: an appeal for medication adherence.

Venerito V, Lopalco G, Iannone F.

Abstract:

Link to Article

How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1.

Conti P, Gallenga CE, Tetè G, Caraffa A, Ronconi G, Younes A, Toniato E, Ross R, Kritas SK.

Abstract:

Link to Article

Arthralgia as an initial presentation of COVID-19: observation.

Joob B, Wiwanitkit V.

Abstract:

Link to Article

COVID-19 outbreak and inflammatory bowel disease management: a questionnaire survey from realistic practice.

Bai X, Yang H, Qian J.

Abstract:

Link to Article

Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?

Ritchie AI, Singanayagam A.

Abstract:

Link to Article

Are patients with inflammatory bowel disease at increased risk for Covid-19 infection?

Monteleone G, Ardizzone S.

Abstract:

Link to Article

Management of IBD during the COVID-19 outbreak: resetting clinical priorities.

Danese S, Cecconi M, Spinelli A.

Abstract:

Link to Article

Inflammatory bowel disease care in the COVID-19 pandemic era: the Humanitas, Milan experience.

Fiorino G, Allocca M, Furfaro F, Gilardi D, Zilli A, Radice S, Spinelli A, Danese S.

Abstract:

Link to Article

The Rheumatologist's Role in COVID-19.

Cron RQ, Chatham WW.

Abstract:

Link to Article

Don't forget chronic lung and immune conditions during covid-19, says WHO.

Thornton J.

Abstract:

Link to Article

Are my patients with rheumatic diseases at higher risk of COVID-19?

Figueroa-Parra G, Aguirre-Garcia GM, Gamboa-Alonso CM, Camacho-Ortiz A, Galarza-Delgado DA.

Abstract:

Link to Article

COVID-19 infection and rheumatoid arthritis: Faraway, so close!

Favalli EG, Ingegnoli F, De Lucia O, Cincinelli G, Cimaz R, Caporali R.

Abstract:

Link to Article

Should biologics for psoriasis be interrupted in the era of COVID-19?

Lebwohl M, Rivera-Oyola R, Murrell DF.

Abstract:

Link to Article

COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action.

Conforti C, Giuffrida R, Dianzani C, Di Meo N, Zalaudek I.

Abstract:

Link to Article

The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China.

Yang Y, Peng F, Wang R, Guan K, Jiang T, Xu G, Sun J, Chang C.

Abstract:

Link to Article

The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak.

Rothan HA, Byrareddy SN.

Abstract:

Link to Article

The Incidence and Outcomes of COVID-19 in IBD Patients: A Rapid Review and Meta-analysis

Aziz M, Fatima R, Haghbin H, Lee-Smith W, Nawras A.

Abstract:

Link to Article

The association between severe or death COVID-19 and autoimmune disease: a systematic review and meta-analysis

Liu M, Gao Y, Zhang Y, Shi S, Chen Y, Tian J.

Abstract:

Link to Article

American College of Rheumatology Guidance for the Management of Adult Patients with Rheumatic Disease During the COVID-19 Pandemic.

Mikuls TR, Johnson SR, Fraenkel L, Arasaratnam RJ, Baden LR, Bermas BL, Chatham W, Cohen S, Costenbader K, Gravallese EM, Kalil AC, Weinblatt ME, Winthrop K, Mudano AS, Turner A, Saag KG.

Abstract:

Link to Article

Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/Covid-19 pandemic.

Schulze-Koops H, Specker C, Iking-Konert C, Holle J, Moosig F, Krueger K.

Abstract:

Link to Article

Immune Thrombocytopenic Purpura in a Patient with Covid-19.

Zulfiqar AA, Lorenzo-Villalba N, Hassler P, Andrès E.

Abstract:

Link to Article

Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in sardinia (Italy).

Atzori L, Mugheddu C, Addis G, Sanna S, Satta R, Ferreli C, Atzori MG, Montesu MA, Rongioletti F.

Abstract:

Link to Article

Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic.

Torres T, Puig L.

Abstract:

Link to Article

Management of Inflammatory Bowel Diseases in the Wake of COVID-19 Pandemic.

Pasha SB, Fatima H, Ghouri YA.

Abstract:

Link to Article

Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs.

Georgiev T.

Abstract:

Link to Article